Genetec maintains profitability in Q3FY2025 on higher revenue

Key Financial Performance Highlights for Q3FY2025:Group’s total revenue for the quarter jumps to RM75.1 million, with e-mobility and energy storage segments as primary contributors, followed by electronicsPerformance for the quarter supported by prompt execution of outstanding orders from FY2024 and progress on new scopes secured within existing client baseBoth PBT and PAT stand at RM3.2 million for the quarter under reviewGP, PBT, PAT, and PATAMI margins recorded at 11.6%, 4.3%, 4.3% and 1.1% respectivelyBANGI, Malaysia, May 29, 2025 - (ACN Newswire via SeaPRwire.com) - Technology leader in providing turnkey, intelligent manufacturing automation solutions, GENETEC TECHNOLOGY BERHAD (“Genetec” or the “Company”), today announced its financial results for the third quarter ended 31 March 2025 (“Q3FY2025”). The Company reported a jump in their revenue to RM75.1 million, on par with the preceding year-on-year revenue levels, supported by the delivery of outstanding and new orders across its core client base. Gross Profit (“GP”) for the quarter came in at RM8.7 million with both profit before tax (“PBT”) and profit after tax (“PAT”) at RM3.2 million, and profit after tax and minority interests (“PATAMI”) at RM0.8 million. GP, PBT, PAT, and PATAMI margins stood at 11.6%, 4.3%, 4.3% and 1.1% respectively.While the Q3FY2025 revenue marked a return to revenue levels previously seen in FY2024, profit margins and PAT for the quarter fell compared with the previous quarter’s PAT of RM6.3 million. The Company noted that this was due to several deliveries in the quarter involving new scopes which involved one-off, non-recurring expenses. Genetec expects margin to normalise in upcoming quarters.Managing Director and Co-founder of Genetec, Chin Kem Weng commented, “Our top-line performance reflects a pickup in project execution and a healthy pipeline on the back of our ongoing client engagement. The margin dip this quarter is temporary, contributed by one-off expenses tied to the new project scopes and are not recurring. As such, we are confident that we will see a recovery in the margins in the coming quarters as project maturity and margin discipline for the new scopes improve. Genetec’s focus remains on deepening our partnerships with clients in key sectors like electric vehicle (“EV”), automotives, and energy storage, while we continue to seek meaningful diversification.”Amid the ongoing shifts in global trade dynamics and supply chain strategies, Genetec sees structural tailwinds supporting its growth trajectory. As manufacturers reassess production footprints and strengthen operational resilience, there is an upward demand for flexible, cost-competitive and reliable high-quality automation solutions. Genetec’s Malaysia-based production model, combined with a proven international track record, deep technical expertise, and agile manufacturing capabilities, positions the Company well to support clients adapting to these changes.The Company remains focused on deepening its engagement with existing customers while exploring opportunities to broaden its client base. In addition to pursuing new scopes within existing clients’ operations, Genetec has actively participated in several international exhibitions and industry events in recent months, which have generated encouraging business leads. These engagements mark early steps toward potential entry into new industries and segments, in line with the Company’s longer-term strategy to diversify and grow.Genetec is also actively managing its current production load while progressing its EPIC plant expansion, scheduled for completion in early 2026. The new facility will significantly increase floor space and technical capabilities, supporting Genetec’s ability to deliver on multiple high-value projects simultaneously.“We remain focused on timely order execution, quality and cost control, and supporting our clients in a rapidly evolving industrial and technological environment. With steady project momentum, a growing base of client engagements, and strategic expansion into new sectors, we are cautiously optimistic about the road ahead. We believe Genetec is well-positioned to build on this foundation for long-term growth,” Chin concluded.With ongoing execution across key client projects and growing interest from new industries, Genetec continues to position itself as a trusted global partner in automation.About Genetec Technology BerhadGenetec Technology Berhad is a public listed company on the Main Market of Bursa Malaysia Securities Berhad (Stock code: 0104) and a global leader in providing customised, turnkey smart factory automation solutions. With a strong international footprint, it serves a diverse range of industries including electric vehicle (EV), e-mobility and energy storage, automotive, hard disk drives (HDD), consumer electronics, appliances, and pharmaceuticals.For more information please visit: https://genetec.net/. Copyright 2025 ACN Newswire via SeaPRwire.com.

Naoris Protocol Raises $3M in Strategic Round Led by Mason Labs

WILMINGTON, DE, May 29, 2025 - (ACN Newswire via SeaPRwire.com) - Naoris Protocol, the first quantum-resistant blockchain and cybersecurity mesh architecture, has raised $3 million in a strategic funding round led by Mason Labs, that includes Frekaz Group, Level One Robotics and Tradecraft Capital following a six-month technical due diligence process.The round, which includes proceeds from Naoris’s public sale and related allocations, was oversubscribed, prompting the team to open a new institutional raise — now live as of today, Thursday, 29 May.David Carvalho, CEO and Founder of Naoris Protocol, says: “The strong interest we’ve seen from institutions reflects how urgently the industry is beginning to take the threat of quantum computing seriously. This investment supports our mission to future-proof the blockchain ecosystem before these risks become reality.”Mason Labs, a leading venture capital firm focused on infrastructure-grade technologies, conducted a detailed review of Naoris Protocol’s post-quantum trust structure prior to securing the entire VIP allocation.Rain Huan, Founder of Mason Labs, says: “In recent years, cybersecurity issues related to digital assets have become increasingly severe and a serious challenge also faced by Mason Labs as an institution focusing on on-chain asset trading and investment. Naoris Protocol’s groundbreaking infrastructure layer has the potential to effectively mitigate such security risks. If successful, this would represent a substantial advancement for the Web3 ecosystem.”This latest round follows a $31 million fundraise in 2022 backed by Tim Draper, the Holdun Family Office, Expert Doja, Uniera and other institutional investors.Naoris Protocol is led by a team of cybersecurity, defense, and blockchain leaders, including:David Holtzman, former CTO of IBM and architect of the DNS protocolAhmed Réda Chami, Ambassador for Morocco to the EU and former CEO of Microsoft North AfricaMick Mulvaney, former White House Chief of StaffInge Kampenes, former Major General (ret.) and Chief of Norwegian Armed Forces Cyber DefenceThe protocol offers a plug-and-play cybersecurity mesh designed to protect any blockchain or enterprise system from the sub-zero layer upward, without requiring a hard fork. Its decentralized security layer is powered by post-quantum cryptography and AI, and aligned with standards from NIST, NATO, and ETSI.Naoris Protocol also runs a quantum-resistant Layer 1 blockchain secured by its proprietary Proof-of-Security (dPoSec) consensus mechanism.About Naoris ProtocolNaoris Protocol is the world’s first Decentralized Post-Quantum Infrastructure, built to secure both Web3 and Web2 against traditional and quantum threats. Operating beneath blockchain layers 0 to 3 as a Sub-Zero Layer, it integrates with existing EVM chains, nodes, bridges, dApps, enterprise systems, and IoT devices without requiring hard forks. Naoris Protocol combines Post-Quantum Cryptography, dPoSec Consensus, and Decentralized Swarm AI to create a self-healing security mesh that eliminates single points of failure. Since launching in January 2025, it has processed over 64 million transactions and mitigated 341 million threats. Powered by the $NAORIS token, it is the fastest-growing trust and security layer for a quantum-resilient internet.To learn more about Naoris Protocol, visit https://www.naorisprotocol.com/ Press contact:Anna Fedorovaanna@babslabs.io  Copyright 2025 ACN Newswire via SeaPRwire.com.

Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully

- ASGH brought together more than 2,900 participants from 42 countries and regions- Medical Fair attracted some 13,000 buyers from 57 countries and regions- The two flagship events together resulted in over 390 deal-making sessions and more than 660 business matching meetings- Collaboration agreements were signed during the events, covering areas including patient care, diagnostic solutions, innovative medical devices, and medical imagingHONG KONG, May 28, 2025 - (ACN Newswire via SeaPRwire.com) – The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. ASGH attracted over 2,900 participants from 42 countries and regions, while the Medical Fair received some 13,000 buyers from 57 countries and regions. Over 390 one-on-one deal-making sessions and more than 660 business matching meetings were arranged, facilitating over 1,000 high-quality collaborations and connections. The IHW continues to foster global exchange and cooperation, putting a spotlight on Hong Kong’s vast potential in healthcare investment and trade, and reinforcing its position as a regional leading medical hub.Dr Peter K N Lam, Chairman of the HKTDC, said: "The Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair concluded with outstanding results driving new collaborations and investments, and injecting new momentum into the healthcare industry. The events brought together leaders across government, business, academia, and investment to tackle today’s healthcare challenges, highlighting Hong Kong’s unique advantages as an international innovation and technology hub under its ‘eight centres’ positioning, actively advancing medical technology, connecting global innovation resources, and paving the way for a healthier and more inclusive future."Over 80 industry experts shared insights on healthcare developmentThe two-day ASGH, jointly organised by the HKSAR Government and the HKTDC under the theme ‘Fostering Global Collaboration for a Shared Future’, focused on a wide spectrum of topics including public health, medical technology breakthroughs, healthy ageing and global business and investment collaboration. The event featured more than 80 speakers comprising government officials and organisations, research pioneers, investors, and business leaders from around the world, all contributing valuable insights to advance global well-being.Prof Lo Chung-mau, Secretary for Health of the HKSAR Government, delivered a keynote speech during the Plenary Session I: Shaping a More Equitable and Sustainable Health System. Other distinguished speakers, including Dr Wu Xiaobin, Vice President of China Pharmaceutical Innovation and Research Development Association; Martin Taylor, Representative to China, World Health Organization; Prof Nancy Ip, President of the Hong Kong University of Science and Technology; and Frédéric Rimattei, Special Envoy for International Affairs of the President of French University Hospitals National Association, shared their insights on tackling global healthcare challenges, offering inspiration for the international healthcare community.In Plenary Session II: Fostering Global Collaboration for a Shared Future, speakers engaged in a lively discussion on trends in global healthcare collaboration. Among them was Ambassador George Hara, Group Chairman and CEO of DEFTA Partners and former Special Advisor to the Cabinet Office of the Prime Minister of Japan, who remarked that more advanced technology and new government regulations are needed to reach a compromise between companies' profits and patients' needs.During the Dialogue with Global Pioneer in Health session, Prof John Hardy, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, shared his latest research findings and advanced developments in Alzheimer's disease.The summit co-organised sessions under the overarching theme, Shaping the Future of Healthcare, with the Hong Kong University of Science and Technology for the first time. The discussion focused on the potential of AI in healthcare and how innovation could drive breakthroughs in the field. Dr Alex Ng, President of Tencent Healthcare, commented: “One uniqueness of tech companies is that they can be easily distracted by the latest thing. But you do need companies with patience and perseverance to stay in healthcare and make it work.” Prof Graham Cooke, Vice-Dean (Research) Medicine of Imperial College London, also noted that embedding patient needs into healthcare systems is critical, as many innovations fail in translation due to a lack of this focus, with universities playing a key role as innovation drivers.In Beyond ‘Healthy China 2030’: Driving Health Innovation, speakers explored opportunities in the mainland healthcare market. Marc Horn, Executive Vice President of Merck and President of Merck China, highlighted the two-phase approach of "China for China" followed by "China for the globe”, emphasising healthcare collaboration to develop advanced treatments for global benefit. Dr Zhang Lianshan, Executive Vice President of Jiangsu Hengrui Pharmaceuticals Co., Ltd., stated: "We would like to see our health innovation have realisation of its value, not only in China, but also outside of China. That is why we are talking about Globalisation, where we can achieve maximum value."With growing global attention on healthy ageing, the summit introduced a dedicated Silver Health Chapter. A highlight was the thematic session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, where Prof Jean Woo, Director of Chinese University of Hong Kong Jockey Club Institute of Ageing, Prof James L. Kirkland, Director of Cedars-Sinai’s Centre for Advanced Gerotherapeutics, and fellow experts explored both the challenges and opportunities posed by ageing populations. Prof Jean Woo highlighted that rapid population ageing is reshaping the global healthcare and socioeconomic landscape. As a city with one of the world’s longest life expectancies, Hong Kong must take early action to strengthen elderly care policies and better allocate health resources. Prof James L. Kirkland also noted that geriatricians ultimately aim to help patients with multiple illnesses reduce medication use while treating their conditions more effectively, enhancing their overall quality of life.Over 390 deal-making sessions and cooperation agreements open new global opportunitiesA key feature of the summit was the ASGH Deal-Making session, which facilitated one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations. Investment projects spanned pharmaceuticals, medical devices and diagnostics, smart healthcare, and community health and wellness and more than 390 one-on-one meetings were successfully arranged for angel investors, venture capitalists, corporate venture arms, private equity firms and family offices.The summit facilitated the signing of cooperation agreements, such as those between Gleneagles Hospital Hong Kong and Emerging Viral Diagnostics, and a tripartite collaboration with PanopticAI and SmartCare, HKSH Medical Group and United Imaging Healthcare, China Resources Guangdong Pharmaceuticals and Hong Kong Medtech Association, Hugobiotech and Bridgeway Healthcare Technology, Canossa Hospital and KA Imaging, and others. These agreements covered diverse healthcare areas, including patient care, diagnostic solutions, innovative medical devices, medical imaging and more. Under the tripartite collaboration agreement between Gleneagles Hospital Hong Kong, PanopticAI, and SmartCare, the integration of PanopticAI’s camera-based vital signs monitoring technology and SmartCare’s patient-centered consultation platform will be implemented into Gleneagles clinic in the future.In addition to its discussion sessions, the summit also featured the ASGH Business Hub, showcasing more than 170 innovative technology companies related to the healthcare industry from 13 countries and regions, including the mainland (Shanghai and Xiamen), Australia, and Thailand, presenting projects and solutions across key areas such as medical innovation, smart healthcare, AI, big data, telemedicine, and cybersecurity. Zhong Wei, Co-founder of Mitrassist Lifesciences, joined the Shanghai Pavilion and said that ASGH helped them bring non-invasive medical monitoring technologies to Southeast Asia, Africa, and other Belt and Road Initiative countries.Medical Fair Drives Industry Innovation and Fosters Business CollaborationThe Medical Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, was held alongside ASGH. The Association—formerly known as the Hong Kong Medical and Healthcare Device Industries Association—held a renaming ceremony during the fair, showcasing the deep integration of medical technology and the industry.The fair brought together some 300 exhibitors from 13 countries and regions, featuring first-time pavilions from the United Kingdom, Thailand and Israel, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg. In addition, seven local universities, over 30 innovative technology companies at the Hong Kong Science and Technology Parks pavilion, and more than 20 medical enterprises brought by the Hong Kong MedTech Association participated. The Hong Kong Council of Social Service also participated in the fair for the first time. Under the theme Innovations Boosting Smart Health Experience, the exhibition spotlighted three major areas: MedTech, GeronTech and green solutions, with many exhibits featuring applications of AI.Many exhibitors and buyers successfully expanded their networks and forged new partnerships at the exhibition. Among them was Hong Kong exhibitor Eieling Technology, a company founded to commercialise research outcomes from the Hong Kong Polytechnic University. The firm showcased its non-invasive liver examination technology, which utilises transient elastography technology. Co-founder and CEO Xiaojia Jia noted that only about four companies worldwide possess this technology, making it a major draw for buyers. "During the exhibition, we received intention orders worth several million Hong Kong dollars from mainland China, Hong Kong, Indonesia, and Thailand, involving around ten devices. This is our third year participating, and we've observed a significant rise in buyers' professionalism during our discussions. We look forward to exhibiting again next year."Karel Lee, CEO of Neoneco from Korea, sourced innovative medical products at the fair with a minimum budget of USD100,000 and he has already identified RhinoCare, an exhibitor from the Israeli pavilion, for its nasal decongestion device, and is also interested in a medical examination device from a Hong Kong exhibitor. Lee stated, "The exhibition allows us to meet with exhibitors face-to-face, build trust, and accelerate the decision-making process. The HKTDC’s Click2Match platform also facilitated efficient business matching. I have already connected with ten exhibitors, and another twenty reached out to me after learning about my sourcing needs. This is one of Asia's premium medical sourcing events, and we will definitely return next year."Beyond business deals, insightful forums were arranged during the Medical Fair to give inspiration to industry buyers. These included The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area, The MedTech Nexus of the Greater Bay Area, co-organised with the Hong Kong MedTech Association, and Fostering Silver Economy, Leading Quality Elderly & Rehabilitation Care Practices, co-organised with the HKCSS. These forums attracted a strong attendance and offered valuable insights into healthcare. Selected sessions are available for replay on the Fair’s website for extended engagement.This year’s Fair continued to adopt the EXHIBITION+ hybrid model. Global exhibitors, industry professionals, and buyers could make use of the Click2Match and explore sourcing opportunities via HKTDC Sourcing (hktdc.com Sourcing). Click2Match will remain available until 4 June.WebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enAsia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/enHong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/enPhoto download:  https://bit.ly/4kbr9NcThe fifth Asia Summit on Global Health was attended by over 2,900 participants from 42 countries and regionsProf Lo Chung-mau, Secretary for Health of the HKSAR Government, delivered a keynote speech on the first day during the Plenary Session I: Shaping a More Equitable and Sustainable Health SystemProf John Hardy, Chair of Molecular Biology of Neurological Disease at UCL Queen Square Institute of Neurology. As an internationally renowned neurogeneticist, Prof John Hardy has been awarded the Brain Prize for "groundbreaking research on the basis of Alzheimer's disease" and is known as the “father of Alzheimer’s disease genetic studies”. He shared his latest research findings and advanced developments during the Dialogue with Global Pioneer in Health sessionWith growing global attention on healthy ageing, the summit introduced a dedicated Silver Health Chapter for the first time. A highlight was the thematic session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, where Prof Jean Woo, Director of Chinese University of Hong Kong Jockey Club Institute of Ageing (far left), and fellow experts explore the challenges and opportunities posed by ageing populationsIn addition to its discussion sessions, the summit also featured the ASGH Business Hub, showcasing more than 170 innovative solutions from the healthcare industry across 13 countries and regionsASGH Deal-making facilitated over 390 one-on-one meetings(Front row from the left) Dr Kyle Wong, Chief Executive Officer and Co-founder of PanopticAI Limited, Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong, and Dr Justin Cheng, Chief Executive Officer and Co-founder of SmartCare Technology Co Limited signed a tripartite cooperation agreement witnessed by (back row from the left) Prof Nancy Ip, President of The Hong Kong University of Science and Technology, Dr Prem Kumar Nair, Group Chief Executive Officer of IHH Healthcare and Patrick Lau, Deputy Executive Director of Hong Kong Trade Development CouncilThe 16th Hong Kong International Medical and Healthcare Fair attracted some 13,000 buyers from 57 countries and regions who visited the fair for sourcing and procurementThe Hong Kong MedTech Association had a delegation of over 20 companies participating in the fair, attracting strong interest from buyers who engaged with exhibitors to explore business opportunitiesThe United Kingdom pavilion, participating in the Medical Fair for the first time, promoted innovative medical devices, solutions and services from multiple companies at the fairAn expert from the Greater Bay Area Center for Medical Device Evaluation and Inspection of the National Medical Products Administration; Eva Wong, Senior Electronics Engineer, Medical Device Division of Department of Health (pictured); along with SGS-CSTC Standards Technical Services Co., Ltd.’s expert, shared insights at The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area forumCo-organised by the Hong Kong Council of Social Service, the Fostering Silver Economy, Leading Quality Elderly & Rehabilitation Care Practices forum drew a strong turnout from industry professionalsMedia enquiriesFor enquiries, please contact Yuan Tung Financial Relations Limited:Louise SongTel: (852) 3428 5691Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Asia Summit on Global HealthSharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgHong Kong International Medical and Healthcare FairKelly ShekTel: (852) 2584 4537Email: kelly.yt.shek@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.  Copyright 2025 ACN Newswire via SeaPRwire.com.

Modern Dental Group’s Thai Subsidiary Hexa Ceram Held 30th Anniversary Celebration and Dental Symposium

HONG KONG, May 28, 2025 - (ACN Newswire via SeaPRwire.com) – Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600.HK), a leading global dental prosthetic devices provider, announced the successful launch of the 30th Anniversary Celebration and Symposium “Hexallence Beyond 30: Pioneering Tomorrow’s Dentistry” by its Thai subsidiary Hexa Ceram Dental Laboratory (“Hexa Ceram”) in Bangkok, Thailand on 24th May. As a crucial segment of Modern Dental Group's strategic framework in the Asia-Pacific region, Hexa Ceram's 30th anniversary celebration is not only a milestone for the industry but also marks a new starting point for the collaborative development of both parties.In the 30 years since its establishment in 1995, Hexa Ceram has been committed to promoting innovation in dental technology. By 2023, its local market share reached 29%, making it the top dental laboratory in Thailand. It has become a benchmark company in the dental field in Thailand and Southeast Asia. Themed "Pioneering Tomorrow’s Dentistry", this year's celebration aims to review the technological advancements and industry contributions of the brand over the past 30 years, and to open up a forward-looking vision in dentistry for practitioners through insightful discussions with top-tier scholars globally. The symposium specially invited 300 dentists, 100 VIP customers in the industry, dean from 10 top universities and presidents of dental associations to jointly build a blueprint for the future development of dentistry. At this new milestone, Hexa Ceram is dedicated to delivering high-quality and innovative dental solutions and services continuously. It is committed to expanding the presence in the ASEAN Economic Community, fostering growth and excellence in dental care.The global dental industry is currently undergoing an accelerated transformation from traditional models to precision-driven and intelligent approaches. With Hexa Ceram officially incorporated into the global system of Modern Dental Group, the two parties will continue to strengthen their leadership in the Thai market through technological innovation, resource synergy and integration, and effectively promote the Group's competitiveness in the global dental industry value chain. Looking ahead, the Group will continue to maintain its focus on digital innovation as a catalyst and give full play to the strategic role of Hexa Ceram to build a dental ecosystem network in Southeast Asia. Through international technology integration, service model advancements and global resource collaboration, we strive to elevate oral diagnosis and treatment technology in Southeast Asia and globally, delivering transformative dental solutions.About Modern Dental Group Modern Dental Group Limited (Stock code: 03600.HK) is a leading global dental prosthetics provider, distributor and consultant with a focus on providing custom-made prostheses to customers in the growing prosthetics industry. Our product portfolio is broadly categorized into three product lines: fixed prosthetic devices, such as crowns and bridges; removable prosthetic devices, such as removable dentures; and other devices, such as orthodontic devices, sports guards, clear aligners, and anti-snoring devices.Modern Dental Group has a global portfolio of respected brands, including Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA and MicroDental in the United States, Modern Dental Pacific in Australia and New Zealand, Modern Dental SG in Singapore, Modern Dental TW in Taiwan, and Apex Digital Dental in Malaysia. We have grown these brands by providing premium and consistent quality products and superior customer service. We have more than 80 service centers in over 28 countries and serve over 30,000 customers. Copyright 2025 ACN Newswire via SeaPRwire.com.

现代牙科集团泰国公司Hexa Ceram举办三十周年庆典暨牙科论坛

香港,2025年5月28日 - (亚太商讯 via SeaPRwire.com) - 全球领先之义齿器材供应商 - 现代牙科集团有限公司 (简称「现代牙科」或「本集团」,股份代号:03600.HK) 旗下泰国牙科实验室Hexa Ceram Dental Laboratory ("Hexa Ceram") 于5月24日在泰国曼谷举办「Hexallence Beyond 30: Pioneering Tomorrow's Dentistry」30 周年庆典暨学术交流论坛。作为现代牙科集团在亚太区域战略版图的重要落子,Hexa Ceram三十周年庆典不仅是行业共襄盛举的里程碑,更标志着双方协同发展的全新起点。自 1995 年成立至今三十年,Hexa Ceram秉持推动齿科技术革新使命,至2023年当地市占率达29%,为泰国TOP1牙科实验室,已成为泰国及东南亚齿科领域标杆企业。本届庆典以「开拓牙科未来」为主题,旨在回顾品牌三十年技术沉淀与行业贡献,通过全球顶尖学者的巅峰对话,为从业者开启齿科领域的前瞻视野。盛典特邀全球300位牙医、100位业界菁英客户、10所顶尖学府院长及牙科协会主席,共绘齿科发展蓝图。在迎接新的里程碑之际,Hexa Ceram将致力于提供高质量、创新的牙科解决方案和服务,持续扩大在东盟经济共同体中的影响力,促进对牙科产业发展的卓越追求与行业进步。当前全球齿科行业正经历从传统诊疗模式向精准化、智能化的加速转型。随着Hexa Ceram正式纳入现代牙科集团全球体系,双方将通过技术创新驱动与资源协同整合,持续强化在泰国市场的领导地位,并有力推动集团在全球齿科产业价值链中的竞争力。展望未来,集团将持续以数码化创新为引擎,充分发挥Hexa Ceram的战略作用构建辐射东南亚的齿科生态网络。通过技术跨界融合、服务模式革新与全球资源联动,集团致力推进东南亚地区以至全球口腔诊疗技术提升,缔造突破性的齿科解决方案。关于现代牙科集团现代牙科集团有限公司 (股份代号: 03600.HK) 为全球领先的义齿器材供应商、经销商和顾问,专注于发展迅速的义齿行业为客户提供定制式义齿。我们的产品组合大致可分为三类﹕固定义齿器材,例如牙冠及牙桥;活动义齿器材,例如活动义齿;及其他器材,例如正畸类器材、透明牙套、运动防护器及防鼾器。现代牙科集团拥有多个备受称许的全球品牌,包括西欧的Labocast、Permadental及Elysee Dental、中国的洋紫荆牙科器材、香港的现代牙科器材、美国的Modern Dental USA及MicroDental 、澳洲及新西兰的Modern Dental Pacific、新加坡的Modern Dental SG、台湾的 Modern Dental TW及马来西亚的 Apex Digital Dental等。我们提供稳定和优质的产品及卓越的客户服务,令这些公司品牌能茁壮成长。我们于全球超过 28个国家拥有超过 80 家服务中心及服务逾 30,000 名客户。 Copyright 2025 亚太商讯 via SeaPRwire.com.

Euro Manganese Closes C$11.2 million (A$12.3 million) Financing

Highlights Financing included an upsized C$9.8 million (A$10.8 million) Private Placement and an oversubscribed A$1.5 million (C$1.4 million) Share Purchase PlanCompany welcomes the European Bank of Reconstruction and Development and Eric Sprott as significant shareholdersFunds raised to support ongoing development of the Chvaletice Manganese Project and customer engagements to secure additional offtake term sheets and strategic investmentsVancouver, British Columbia--(ACN Newswire via SeaPRwire.com - May 28, 2025) - Euro Manganese Inc. (TSXV) (ASX: EMN) (FSE: E060) (the "Company" or "Euro Manganese") is pleased to announce that, following the approval by its shareholders at its Annual General and Special Meeting held on May 15, 2025 (the "AGSM"), it has closed the previously announced financing package which included: (a) a private placement (the "Placement") of common shares ("New Shares") and CHESS Depositary Interests ("New CDIs" together with the New Shares, "New Securities") in the capital of the Company of C$9.8 million (approximately A$10.8 million); and (b) a Share Purchase Plan ("SPP", together with the Placement, the "Financing") with certain eligible shareholders in the amount of A$1.5 million (approximately C$1.4 million). The Company also announces an option grant to certain directors, officers, employees, and consultants as described below.Martina Blahova, CEO of Euro Manganese, commented:"We are extremely pleased with the strong support demonstrated by both our existing shareholders and new investors, including the notable participation of Mr. Eric Sprott. As Euro Manganese's largest shareholder, EBRD's investment reinforces its support and commitment to the Chvaletice Project. This critical financing enables the Company to pursue certain key milestones and advance project development. We thank shareholders for their ongoing support."The net proceeds of the Financing will be used to support ongoing development of the Chvaletice Manganese Project, including customer engagements to secure additional offtake term sheets and strategic investments, the operation of the demonstration plant, as needed, to market the Company's product to potential customers and to advance permitting.All defined terms in this press release have the same meaning as set out in the press releases dated March 6, 2025 and April 1, 2025, unless such terms are otherwise defined herein.Details of the PlacementThe Placement consisted of the issuance of an aggregate of 54,578,350 New Securities, comprised of 39,671,662 New Shares at a price of C$0.18 per New Share and 14,906,688 New CDIs (with each New CDI representing one New Share) at a price of A$0.195 per New CDI, and 54,578,350 Warrants for aggregate gross proceeds of C$9.8 million (approximately A$10.8 million). Warrants issued in connection with the Placement are exercisable any time prior to November 28, 2026 (Vancouver), and have an exercise price of C$0.225 per New Security. Included in the Placement were:14,650,278 New CDIs and 14,650,278 Warrants subscribed for under the Placement led by the Joint Lead Managers (as defined below);39,463,331 New Shares and 39,463,331 Warrants subscribed for directly with the Company, which included (i) 21,400,000 New Shares and 21,400,000 Warrants subscribed for by the European Bank for Reconstruction and Development ("EBRD") (the "EBRD Subscription"); (ii) 16,666,666 New Shares and 16,666,666 Warrants subscribed for by Mr. Eric Sprott, through 2176423 Ontario Ltd., a corporation which is beneficially owned by Mr. Sprott; and (iii) 1,396,665 New Shares and 1,396,666 Warrants subscribed for by other, non-related investors; andsubscriptions by directors of the Company for 464,741 New Securities (comprised of 208,331 New Shares and 256,410 New CDIs) and 464,741 Warrants (the "Related Party Subscription").As the number of New Securities and Warrants issued under the Placement led by the Joint Lead Managers, pursuant to the EBRD Subscription, and subscribed for directly with the Company exceeded the number of securities permitted to be issued without obtaining prior shareholder approval under Listing Rule 7.1 of the Australian Securities Exchange ("ASX"), the Company was required to seek shareholder approval. Similarly, the Related Party Subscriptions were subject to shareholder approval as required by ASX Listing Rule 10.11.1 and 10.11.4. Resolutions approving these issues were sought and received at the AGSM.Since certain directors and management of the Company participated in the Placement, the Placement is considered to be a related party transaction subject to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101 on the basis that participation in the Placement by such directors and management does not exceed 25% of the fair market value of the Company's market capitalization, as calculated in accordance with MI 61-101.Details of the Share Purchase PlanThe SPP was conducted pursuant to a Prospectus dated April 23, 2025 and was comprised of 7,692,307 New CDIs at a price of A$0.195 per CDI, and 7,692,307 Warrants, for aggregate gross proceeds of A$1.5 million (approximately C$1.4 million). Warrants issued in connection with the SPP are exercisable any time prior to November 28, 2026 (Vancouver), with an exercise price of C$0.225 per New Security.As announced in the Company's news release of May 15, 2025, the SPP was oversubscribed and subscriptions were scaled back to the maximum aggregate amount permitted.As the number of New CDIs and Warrants issued under the SPP exceeded the Company's Placement Capacity under ASX Listing Rule 7.1, the Company was required to seek shareholder approval, such approval having been received at the AGSM.Broker Fees and Additional WarrantsCanaccord Genuity (Australia) Limited ("Canaccord Genuity") and Foster Stockbroking Pty Ltd ("FSB", together with Canaccord Genuity, the "Joint Lead Managers") acted as Joint Lead Managers and Bookrunners for the Financing. Aggregate fees payable in cash by the Company to Canaccord Genuity and FSB in connection with the Financing consisted of A$498,918 (approximately C$454,016).In addition, the Company also issued 4,904,478 broker warrants (the "Broker Warrants") to Canaccord Genuity and FSB, representing 12% of the aggregate number of New Securities issued under the Placement and the SPP, excluding those issued pursuant to the EBRD Subscription. The Broker Warrants are exercisable any time prior to May 28, 2027 (Vancouver), with an exercise price of C$0.225 per New Security.Additionally, as announced previously on March 6, 2025 and April 1, 2025, and in connection with an amendment to the Company's Convertible Loan Royalty Agreement (the "CLRA") with OMRF (BK) LLC ("Orion") the Company has issued 22,263,733 warrants to purchase New Securities (the "Additional Warrants") to Orion, exercisable any time prior to November 28, 2026 (Vancouver), with an exercise price of C$0.225 per New Security. Additional details about the CLRA are available in the news releases of the Company dated December 3, 2024, November 29, 2023 and November 27, 2023.As the number of the Broker Warrants and Additional Warrants exceeded the Company's Placement Capacity under ASX Listing Rule 7.1, the Company was required to seek shareholder approval, such approvals having been received at the AGSM.Applicable Hold PeriodsNew Shares issued or made issuable under the Financing will not be permitted to be traded in or into Canada or through the facilities of the TSX Venture Exchange (the "TSX-V") prior to a four month and one day statutory hold period expiring on September 29, 2025 (Vancouver), and will be subject to legending requirements under Canadian securities laws. New Shares will be listed on the TSX-V and New CDIs listed on the ASX. The Warrants, Broker Warrants and Additional Warrants will not be listed. New CDIs will not be permitted to be exchanged for common shares and traded through the facilities of the TSX-V prior to the four month and one day statutory hold period expiring on September 29, 2025 (Vancouver).The Warrants, Broker Warrants and Additional Warrants will not be listed. Common shares issued upon exercise of the Warrants, Broker Warrants or Additional Warrants prior to September 29, 2025 (Vancouver) are subject to the same restrictions noted above.The Warrants, Broker Warrants or Additional Warrants may not be traded in or into Canada prior to September 29, 2025 (Vancouver) and will be subject to legending requirements under Canadian securities laws.Early Warning Disclosure for The European Bank for Reconstruction and DevelopmentEBRD acquired the 21,400,000 units pursuant to the Placement at a price per unit of C$0.18 for total consideration of C$3,852,000.Prior to the completion of the EBRD Subscription, EBRD owned 3,560,000 common shares, representing an ownership interest of 4.42% of the issued and outstanding common shares of the Company. On completion of the EBRD Subscription, EBRD's ownership interest increased to 24,960,000 common shares, representing an ownership interest of 17.48% of the issued and outstanding common shares and an increase of 13.06%. Assuming the exercise by EBRD of all its Warrants, and assuming the exercise of (i) all Warrants issued under the Placement, (ii) all Warrants issued under the SPP, and (iii) all Additional Warrants, EBRD's ownership interest will be in aggregate 46,360,000 common shares, representing an aggregate beneficial ownership interest of 19.96% of the issued and outstanding shares and an increase of 15.54%. EBRD has agreed, pursuant to the terms of the Warrants issued to EBRD, that for so long as the Company is listed on the TSX-V, unless approval from the TSX-V and disinterested shareholders of the Company have been obtained pursuant to the policies of the TSX-V (provided that such approval is required at the relevant time), EBRD will not be permitted to exercise such number of warrants that would result in it beneficially owning more than 19.99% of the outstanding common shares of the Company.EBRD acquired the New Shares and Warrants for investment purposes. Depending on market conditions and other factors, EBRD may from time to time acquire and/or dispose of securities of the Company or continue to hold its current position.To obtain a copy of the early warning report to be filed by EBRD in connection with this press release, please contact: Michael Zlobin at +44 207338 8981. EBRD's address is 5 Bank Street, London, E14 4BG, United Kingdom.Early Warning Disclosure for Eric SprottEric Sprott, through 2176423 Ontario Ltd., a corporation that is beneficially owned by him acquired 16,666,666 units pursuant to the Placement, at $0.18 per unit for total consideration of C$3,000,000. Prior to the Placement, Mr. Sprott did not beneficially own or control any securities of the Company. As a result of the Placement, Mr. Sprott now beneficially owns 16,666,666 Shares and 16,666,666 Warrants, representing approximately 11.7% of the outstanding Shares on a non-diluted basis and 20.9% of the outstanding Shares on a partially-diluted basis assuming exercise of such Warrants.The securities are held for investment purposes. Mr. Sprott has a long-term view of the investment and may acquire additional securities including on the open market or through private acquisitions or sell the securities including on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.A copy of the early warning report with respect to the foregoing will appear on Euro Manganese's profile on SEDAR+ at www.sedarplus.ca and may also be obtained by calling Mr. Sprott's office at (416) 945-3294 (2176423 Ontario Ltd., 7 King Street East, Suite 1106, Toronto Ontario M5C 3C5).Option GrantThe Company today also granted stock options ("Options") to certain of its directors, officers, employees, and consultants to purchase up to an aggregate of 7,020,000 common shares ("Shares"). Of these, 1,330,000 Options have been granted to directors, 2,530,000 Options have been granted to officers, and 3,160,000 Options have been granted to employees and consultants. The Options are exercisable for a term of ten years at an exercise price of CAD$0.19 per Share. All of the Options will vest one-third immediately and then one third on each of the first and second anniversaries of today's date of grant, except that 1,650,000 of the Options granted to certain officers, employees and consultants will all vest immediately in recognition of such individuals work in managing the successful completion of the oversubscribed Financing.Interim CFOAs announced earlier this month, the Company will be appointing a new Chief Financial Officer ("CFO") in the coming weeks. Until such time, following the departure of Dean Larocque as CFO on May 30, 2025, Martina Blahova will serve as interim CFO.About Euro Manganese Euro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry. The Company is advancing development of the Chvaletice Manganese Project in the Czech Republic and an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec.The Chvaletice Project is a unique waste-to-value recycling and remediation opportunity involving reprocessing old tailings from a decommissioned mine. It is also the only sizable resource of manganese in the European Union, strategically positioning the Company to provide battery supply chains with critical raw materials to support the global shift to a circular, low-carbon economy.Euro Manganese is dual listed on the TSX-V and the ASX.Authorized for release by the CEO of Euro Manganese Inc.Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) or the ASX accepts responsibility for the adequacy or accuracy of this release. Enquiries Martina BlahovaChief Executive Officer+1 (604) 681-1010martina@mn25.caLodeRock AdvisorsNeil WeberInvestor and Media Relations - North America+1 (647) 222-0574 neil.weber@loderockadvisors.comJane Morgan Management Jane Morgan Investor and Media Relations - Australia +61 (0) 405 555 618 jm@janemorganmanagement.com.auCompany Address: #709 -700 West Pender St., Vancouver, British Columbia, Canada, V6C 1G8Website: www.mn25.caFollow us on: LinkedIn | Twitter | YouTubeClick Here to Subscribe to our mailing list for updatesForward-Looking StatementsCertain statements in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, its Chvaletice Project, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", "scheduled", "forecast", "predict" and other similar terminology, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company.All forward-looking statements are made based on the Company's current beliefs including various assumptions made by the Company including that the Chvaletice Project will be developed and operate in accordance with current plans, appointment of permanent CFO, that the Company will be able to raise the financing that it requires, and that it will meet conditions of its secured credit facility. Factors that could cause actual results or events to differ materially from current expectations include, among other things: risks and uncertainties related to the Company's ability to meet the conditions of its secured credit facility, risks related to maintaining and securing necessary licenses or permits; risks related to acquisition of surface rights; inability to secure sufficient offtake agreements; the availability of acceptable financing; the potential for unknown or unexpected events to cause contractual conditions to not be satisfied; developments in EV (Electric Vehicles) battery markets and chemistries; and risks related to fluctuations in currency exchange rates, changes in laws or regulations; and regulation by various governmental agencies. For a further discussion of risks relevant to the Company, see "Risk Factors" in the Company's annual information form for the year ended September 30, 2024, available on the Company's SEDAR+ profile at www.sedarplus.ca.Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release.NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/253771 Copyright 2025 ACN Newswire via SeaPRwire.com.

SAPPE Makes a Global Splash in the Beverage Market, Unveils Global Campaign “Life’s too Short, You Gotta Chew” at THAIFEX – ANUGA ASIA 2025

BANGKOK, May 28, 2025 - (ACN Newswire via SeaPRwire.com) - Sappe PCL (SAPPE), a pioneer in beverage innovation from Thailand that has gained recognition among consumers worldwide, is set to reinforce its global brand ambition at THAIFEX – ANUGA ASIA 2025, Asia’s premier food and beverage trade exhibition. The event will take place from May 27–31, 2025, at Booth 1-QQ01, Impact Challenger Hall 1, Muang Thong Thani, Bangkok, Thailand.The highlight of this year’s showcase is the official launch of Mogu Mogu’s new global campaign, “Life’s too Short, You Gotta Chew” presenting the world’s first Snackable Drink, a category created by SAPPE itself. The campaign marks a major milestone in reshaping the global beverage experience by blending taste, texture, and lifestyle in one fun and refreshing product.Mission to Mars: A Thai Brand Journey to the Future of Global GrowthUnder the concept of “Mission to Mars,” SAPPE’s exhibition booth is designed to resemble a spacecraft transporting over 10 beverage brands from Thailand on a journey into the future. The concept symbolizes bold creativity, forward thinking, and the ambition to share Thai-made innovations with consumers worldwide.Featured products include Mogu Mogu, Sappe Aloe Vera, Sappe Beauti, and the company’s newest innovations designed with a strong focus on quality, taste, functionality, health benefits, and environmental responsibility, to meet the evolving preferences of today’s global consumers.Mogu Mogu: Turning Ordinary Days into Chewable FunThe “Life’s too Short, You Gotta Chew” campaign makes its global debut at the event, supported by three vibrant new TV commercials. The campaign highlights Mogu Mogu’s playful, upbeat personality and connects with today’s young consumers who seek Social Connection, FOMO (Fear of Missing Out), Instant Gratification, and a lifestyle filled with fun and spontaneity.SAPPE is working with key partners in major international markets including South Korea, Philippines, France, and the United Kingdom to expand the campaign’s global reach and deepen engagement with Mogu Mogu’s growing fan base. The company aims to significantly increase international brand engagement by the end of this year.Beyond Export: SAPPE’s Vision to Build a Lasting Global BrandMs. Piyajit Rackariyapong, Chief Executive Officer of SAPPE, said:“We don’t just export beverages. Our mission is to build a brand from Thailand that leads with innovation, offers new excitement and drinking experiences to consumers, and brings positivity into people’s everyday lives.”SAPPE’s consistent participation in THAIFEX – ANUGA ASIA for over a decade reflects the company’s commitment to becoming a creative force in the global beverage industry driven by bold ideas, cultural connection, and consumer empathy.THAIFEX – ANUGA ASIA: A Global Value Chain GatewayOrganized by Thailand’s Department of International Trade Promotion (DITP) in partnership with the Thai Chamber of Commerce and Koelnmesse Germany, THAIFEX – ANUGA ASIA serves as a critical platform for Asian food and beverage brands to connect with the global value chain. SAPPE continues to be one of the most prominent Thai brands recognized annually on this stage.Visit SAPPE at Booth 1-QQ01, IMPACT Challenger Hall 1, Muang Thong Thani, Bangkok, Thailand, throughout the 5-day event. Follow Mogu Mogu’s global journey at www.mogumogu.comAbout SAPPESappe Public Company Limited (SAPPE) is a leading Thai beverage innovator and the owner of several iconic brands. The company specializes in fruit juice and functional drinks, developed to serve the modern lifestyle of consumers across global markets. SAPPE currently exports to over 100 countries worldwide, with a strong presence in Asia, Europe, and the Middle East.Its portfolio includes globally recognized brands such as Mogu Mogu, the world’s first Snackable Drink; Sappe Aloe Vera, known for its refreshing taste and natural ingredients; and Sappe Beauti, a health-focused functional drink line. SAPPE is headquartered in Bangkok, Thailand, and is listed on the Stock Exchange of Thailand (SET) under the symbol SAPPE.Driven by innovation, consumer insights, and sustainability, SAPPE is committed to delivering high-quality products that bring joy, well-being, and new experiences to people around the world.Sappe official: https://www.sappe.com/en/Facebook:  https://www.facebook.com/sappeplaygroundInstagram:  https://www.instagram.com/mogumogu_global/Line:  https://shop.line.me/@sappeonlineShopee:  https://shopee.co.th/sappe.officialEmail: corpcom@sappe.com Copyright 2025 ACN Newswire via SeaPRwire.com.

Top Business and Policy Leaders to Convene at CGS International’s ASEAN Business Forum 2025 to Scale Intra-ASEAN and International Trade and Investment

KUALA LUMPUR, May 27, 2025 - (ACN Newswire via SeaPRwire.com) - CGS International Securities Pte Ltd (“CGS International”) and CGS International Securities Malaysia Sdn Bhd (“CGS MY”) in collaboration with MBSB and OCBC Malaysia, today at their curtain raiser for the inaugural ASEAN Business Forum 2025 (“ABF2025” or the “Forum”), shared key action points slated for intense discussion at the event to be held on 29 May 2025. ABF2025 will be held in conjunction with the 46th ASEAN Summit 2025 in Kuala Lumpur, and the ASEAN-GCC + China Summit 2025. A key highlight of the forum is the corporate engagement and business exchange session designed to drive real business collaboration between pre-screened and pre-selected matching parties from the top 25 corporations and investors across ASEAN and China.From left to right: En. Khairi Shahrin Arief Baki, Deputy CEO of CGS MY, Mr. Sivasuriyamoorthy Sundara Raja, Deputy CEO of MIDA (Investment Promotion and Facilitation), Puan Azizah Mohd Yatim, CEO of CGS MY, YBhg. Tan Sri NazirRazak, Chairman of the ASEAN-BAC for Malaysia, Ms. Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia, YBhg. Dato' Azlan Shahrim, Group Chief Strategy Officer of MBSB Berhad, and Mr. Alan Inn Wei Loon, Deputy CEO of CGS MY at the Curtain Raiser for the ASEAN Business Forum 2025.Themed “From Vision to Reality – ASEAN Partnerships Fuelling Sustainable Growth”, the forum is co-hosted with the Malaysian Investment Development Authority (MIDA) and ASEAN Business Advisory Council (ASEAN-BAC) Malaysia. It is expected to draw more than 600 attendees comprising over 200 foreign and local corporates, policymakers and corporate captains. They represent the region’s largest companies of over RM1 trillion in market capitalisation, council members of ASEAN BAC countries, and fund managers with total funds under management of over RM 8 trillion. The gathering comes at a critical juncture of a changing world order arising from United States tariffs, as affected countries explore alternative strategies to sustain economic stability and growth.Present at the curtain raiser were CGS International’s strategic partners, represented by YBhg. Tan Sri Nazir Razak, Chairman of the ASEAN-BAC for Malaysia, Mr. Sivasuriyamoorthy Sundara Raja, MIDA Deputy Chief Executive Officer (Investment Promotion and Facilitation), YBhg. Dato’ Azlan Shahrim, Group Chief Strategy Officer representing MBSB Berhad and Ms. Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia – both trusted banking partners committed to growing ASEAN financial ecosystems and supporting sustainable investment flows.Mr. Sivasuriyamoorthy Sundara Raja, MIDA Deputy CEO (Investment Promotion and Facilitation) shared, “We commend CGS International Securities for hosting the ASEAN Business Forum 2025 — a timely effort that speaks to the region’s shared aspiration for sustainable and inclusive prosperity, amidst geopolitical and challenging global economic landscape. At MIDA, we are committed to partnerships that go beyond transactions, that shape long-term value for Malaysia and uplift business communities. This forum bodes well with the statement of intent by ASEAN — to lead with shared purpose, unity, and economic vision. As the Malaysian government’s principal promotion agency, MIDA stands ready to facilitate investments that strengthen regional supply chain integration and elevate ASEAN on the global stage.”YBhg. Tan Sri Nazir Razak, Chairman of the ASEAN-BAC for Malaysia added, “Now, more than ever, ASEAN needs to strengthen bilateral ties and stay united. We need to be deliberate and realistic, taking concerted efforts to optimise intra-ASEAN trade and investments. Amongst our 12 priorities, initiatives such as the ASEAN Business Entity (ABE) directly facilitate this by enabling operational flexibility to ASEAN-based companies to move business, capital, and talent, which will in turn allow emerging businesses and markets to flourish.”In her opening presentation, Puan Azizah Mohd Yatim, CEO of CGS MY said, “This forum marks a major milestone in our ongoing efforts to attract more investment and trade to the region by leveraging CGS International Group’s Chinese parentage. Malaysia’s Chairmanship of ASEAN is happening at a unique time of a shifting world economy. Together with our fellow ASEAN members, we have a golden opportunity to co-ordinate and re-establish deeper, stronger intra-ASEAN, ASEAN+3 and global ties. Through our deep ASEAN network and parentage, we can connect and support the capital needs of businesses in the region and help investors navigate cross-border investments confidently. To date, we have organised and facilitated B2B and B2G engagements for companies and policymakers with China, working towards uplifting ASEAN’s businesses and economies.”On behalf of MBSB Group, its Chief Strategy Officer Dato’ Azlan Shahrim highlighted, “Our active participation in the ASEAN Business Forum reflects our commitment to catalysing deeper collaboration across the region. At MBSB Group, we are committed to advancing Malaysia’s regional and global ambitions through our unique combination of MBSB Bank’s banking solutions and MIDF’s development finance expertise. With focus on high-impact sectors such as renewable energy, electrical and electronics, aerospace, agri-foods, and halal, we provide bespoke services that empower businesses and SMEs to grow strategically across ASEAN and beyond. Through our investment banking services, Shariah advisory expertise, and commitment to sustainability, we are helping companies raise capital and scale, in line with the region’s evolving economic landscape.”Ms Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia, concluded, “At OCBC, we believe ASEAN’s strength lies in its connectivity — the seamless integration of markets, talent, and capital, underpinned by sustainable growth. Our participation in ABF2025 underscores our commitment to facilitate cross-border economic collaboration. Through OCBC Group’s integrated global network – spanning corporate & investment banking, private banking, asset management and insurance – we empower businesses to unlock growth opportunities that transcend borders. With our deep-rooted presence in ASEAN and Greater China, OCBC is uniquely positioned to deliver tailored sustainable and Islamic financial solutions as well as bespoke M&A advisory to facilitate trade and investment flows. Together, we are bridging economies while building a resilient, net-zero future for ASEAN.”The full-day forum will feature more than 20 speakers and panellists for discussions as well as closed- door meetings between investors and policy makers, all focused on addressing challenges and catalysing opportunities for high-value deals and strategic partnerships for regional economic growth. Several memoranda of understanding (MOUs) will be announced during the Forum, signalling long- term collaboration in strategic growth sectors such as healthcare, investments, single family office, and trade. In addition to the MOUs, China Galaxy Securities and CGS International Group intend to establish a China-Malaysia and ASEAN investment programme, which aims to foster capital flows, build stronger investment linkages, and support co-investment opportunities amongst China, Malaysia and ASEAN countries, with Malaysia as a key regional anchor. Copyright 2025 ACN Newswire via SeaPRwire.com.

联想控股旗下君联资本及联想之星共同投资企业派格生物医药在港交所成功上市

消息来源:联想之星、君联资本微信公众号香港,2025年5月27日 - (亚太商讯 via SeaPRwire.com) - 5月27日,联想控股(3396.HK)旗下君联资本及联想之星共同投资的慢病创新药企业派格生物医药(02565.HK)在香港联交所成功上市。招股期间,派格生物医药香港公开发售认购额达到743.78倍。派格生物医药成立于2008年,是一家专注于自主研究及开发慢性病创新疗法的生物技术公司,重点关注内分泌代谢领域。派格生物医药针对慢病领域未被满足的临床治疗需求,利用自主开发的技术体系,设计和筛选具有"新靶标、新位点、新机制"的创新分子实体,形成优势互补、多重获益的产品管线。依靠高效及经验丰富的研发团队,通过自主研发,开发了一系列包括多肽药物、蛋白质药物及小分子药物在内的优势产品。派格生物医药构建了以代谢性疾病为核心,广泛覆盖多种慢病的研发管线,公司已自主开发一款核心产品及其他五款在研产品,以把握2型糖尿病(T2DM)、肥胖症、代谢功能障碍相关脂肪性肝炎(MASH)、阿片类药物引起的便秘(OIC)及先天性高胰岛素血症等常见慢病及代谢疾病的巨大市场机会。按照公司规划,治疗2型糖尿病的PB-119预计将于2025年上半年获准在中国上市。这也意味着,派格生物医药即将成功实现商业化落地。作为创新药企业,派格生物医药始终坚持自主研发,截至最后实际可行日期,公司拥有83项专利和专利申请,包括与核心产品有关的13项专利和15项专利申请,且所有重大专利及专利申请均为自有,临床候选药物均来自公司的HECTOR®平台及聚乙二醇(PEG)化技术。对此,联想之星总裁、主管合伙人王明耀表示,"祝贺派格生物成功上市,联想之星有幸长期陪伴并与其一路成长。在多年深耕中,派格生物最终做出令人惊叹的国产创新好药。凭借深厚积累和技术优势,相信他们在生物医药行业能够继续创造出更大的价值。"联想之星与派格生物结缘可追溯到2010年,当时联想之星已经成立了当时国内最大的天使基金,并且将生物医药当作重点方向之一进行投资布局。作为苏州工业园区为发展生物医药产业而建立的专业科技创新载体 - 苏州生物医药产业园,自然成为联想之星重点关注的对象。巧合的是,派格生物刚好是最早一批入驻这个园区的企业。这家专注于慢性病创新疗法的生物技术公司,正好符合联想之星的投资主题。与派格生物接触的过程中,联想之星发现对方自主开发的GLP-1受体激动剂 - PB-119,不仅能治疗2型糖尿病及肥胖症,而且与同类产品相比效果更好、成本更低。当时,仅中国的糖尿病患者人数就已经达到数千万。有数据显示,2021年,中国糖尿病发病人数就已超过400万,患病总人数超过1.17亿,死亡人数超过17.8万。其中,2型糖尿病是最常见的糖尿病类型。更为重要的是,派格生物创始人徐敏拥有哥伦比亚大学生物物理学博士学位,并且在《科学》等期刊上共发表六篇文章,还曾经长期在中国生物医药行业做过风险投资和项目孵化,工作和管理经验相当丰富。据联想之星合伙人陆刚回忆,"不管是在药物研发上的严谨和扎实,还是拥有非常清晰的商业意识,亦或是对市场竞争情况以及药物未来市场定位的精准判断,徐敏都给我们留下了深刻的印象。"再加上合适的价格,联想之星很快便做出投资派格生物的决定。2011年,联想之星在对方新一轮融资中投资了120万美元,与此同时,派格生物也成为联想之星真正意义上投资的第一个生物医药项目。三年后,这家公司不仅已经在国家十二五规划"重大新药创制"科技重大专项的政府支持下启动PB-718的研发项目,而且这款产品还获得I期临床试验的IND(新药临床试验申请)批准。当派格生物需要资金支持时,联想之星又及时伸出援手,果断于2014年追加投资了对方100万美元,让派格生物成为自己的第一个追投项目。此外,除了通过整合中国科学院与联想控股强大的导师和资源的"联想之星创业CEO特训班"帮助徐敏提升创业理念和管理能力,联想之星还积极为派格生物对接君联资本等投资方来解决对方发展所需的资金问题。随着上市钟声的响起,联想之星也在长期的陪伴中,获得了13倍的投资回报。王明耀表示,联想之星更加看重的是,派格生物不仅成功穿越了多个周期,最终还做出了令人惊叹的国产创新好药,"一方面,体现了联想之星深耕生物医药行业的巨大价值;另一方面,这家公司的成功为生物医药行业提供了借鉴价值。"在联想之星的积极对接之下,联想控股旗下君联资本亦于2014年、2016年两次投资派格生物医药,一路支持公司发展。投资后,君联资本在高管招聘、后续融资、BD合作等方面为派格生物医药提供了帮助。对于派格生物医药的成功上市,君联资本表示祝贺,并认为公司从创立初期发展至今,实现了里程碑式的跨越。君联资本表示,见证了公司在慢病创新药研发领域的深耕与突破,此次成功登陆港交所不仅是市场对派格生物医药技术实力与长期价值的认可,更是中国创新药发展的更进一步。公司看好派格生物医药上市后将进一步释放产品及研发潜能,加速惠及全球患者。 Copyright 2025 亚太商讯 via SeaPRwire.com.

GMG Announces Internal G(R) Lubricant Testing Results Showing 10% Fuel Savings and 33% Reduction in Particulate Emissions

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - May 27, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce the following internal GMG run engine test results when G® Lubricant was added to a Caterpillar 22 kVA diesel engine run at an 80% Load. Test results show a 10% increase in energy efficiency (kwh/litres), and also a 33% reduction in harmful diesel engine exhaust particulate matter emissions, when three doses of G® Lubricant, with a maximum graphene dosage of 0.03%, was added to the standard diesel engine oil.It is noted that the test engine was not operating optimally before G® Lubricant was added - the engine was overheating at long runs of sustained high loads. As a result, after the initial dose of G® Lubricant was added, an additional two dosages of G® Lubricant were used to hopefully bring the engine into a more stable operating regime, an outcome that was generally achieved.Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_gmg_image.jpgBuy Now at: www.G-Lubricant.com Figure 2 and 3 show the table and graph distribution of engine efficiency of the various dosages of G® Lubricant versus the baseline.Baseline Diesel Engine OilEngine Efficiency (kwh/litres)G® Lubricant (0.01%)Engine Efficiency (kwh/litres)G® Lubricant (0.02%)Engine Efficiency (kwh/litres)G® Lubricant (0.03%)Engine Efficiency (kwh/litres)3.043.36 (10% increase)3.35 (10% increase)3.36 (10% increase)Figure 2: Engine Efficiency Performance Increase from G® LubricantFigure 3: % Distribution of Fuel Efficiency Relative to BaselineTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_d626526a342c2ac9_005full.jpgFigures 4 and 5 show the table and graph distribution of diesel engine particulate matter emissions of the various dosages of G® Lubricant versus the baseline.Baseline Diesel Engine OilParticulate Matter (ppm)G® Lubricant (0.01%)Particulate Matter(ppm)G® Lubricant (0.02%)Particulate Matter (ppm)G® Lubricant (0.03%)Particulate Matter (ppm)20.9715.56 (26% reduction)14.55 (31% reduction)13.97 (33% reduction)Figure 4: Engine Emission Particulate Matter Reduction from G® LubricantFigure 5: % Distribution of Particulate Matter in Emissions Relative to BaselineTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_d626526a342c2ac9_006full.jpgFigure 6 shows the exhaust emissions of the diesel engine at various dosages of G® Lubricant, versus the baseline which shows similar levels as the baseline test runs. More testing is being done to get more detail on the impact of G® Lubricant across engine emissions. % O2ppm COppm NO% CO2°C FTppm NOxppm NO2Baseline (DEO)7.8151.5359.69.830.0362.22.7DEO + 1% G® Lubricant7.5161.3383.510.028.1386.73.3DEO + 2% G® Lubricant7.5170.6377.010.027.6379.82.8DEO + 3% G® Lubricant7.4184.8388.710.128.4391.42.7Figure 6: Emissions Data for G® Lubricant Relative to BaselineDetailed Equipment and Process for Testing G® LubricantThe following describes the equipment used and the process followed by the Company in demonstrating the fuel saving demonstration of the G® Lubricant in the diesel engine generator:The same testing equipment, data systems and processes were used which was verified by the University of Queensland and detailed in GMG's previous press release on the 25th February, https://graphenemg.com/gmg-unveils-g-lubricant-engine-performance-testing-results-a-transformative-graphene-energy-saving-solution-for-the-multi-trillion-dollar-global-liquid-fuel-industry/GMG also added the following testing equipment to the testing program:Testo 340 Diesel Kit 2 engine emissions test kit which was newly calibrated by the third-party supplier.PDSA DPM-RT-2 particulate matter test unit which was newly calibrated by the third-party supplier.A 22kVA Caterpillar diesel engine generator (with 1,959 hours of run time) was setup in the GMG Richlands warehouse.The generator was connected to a 40-kW power load bank which consumed the energy produced by the generator and created the load and a 500-litre self-contained fuel tank.Two calibrated flow sensors were connected (inflow and return/outflow) to the fuel lines and to a data logger which recorded the fuel consumption.An Energy Analyzer was used to log and track energy produced by the generator.Tests were conducted on 80% loads of the engine from the 40-kW power load bank - 22 kW.A baseline to record diesel fuel consumption under normal engine oil and operating conditions was completed with newly changed recommended premium diesel engine oil and a new oil filter. This oil change was carried out by a professional engine maintenance service company.The engine was run at 80% load and the baseline and G® Lubricant data set used for the analytics is when the maximum ambient temperature for the day was less than 33 degrees Celsius and relative humidity was between 50% and 80% with no rain. Fuel consumption for diesel engines changes when operating in rain or very high humidity or temperatures, so the fuel consumption data baseline and G® Lubricant engine oil additive performance testing were excluded for these times.Only steady state data was used and so any variance or anomalous data seen in either baseline or G® Lubricant datasets were removed from the analytics. Data sets were grouped into minute blocks.Once the baseline fuel tests were completed, G® Lubricant with approximately 1:100 concentration was mixed at approximately 1% ratio by weight into the existing engine oil. This was done another 2 times. The end ratio of GMG's Graphene to the diesel engine oil was approximately 3:10,000 by weight.GMG's Managing Director and CEO, Craig Nicol, commented: "G® Lubricant is not only increasing fuel efficiency it is also reducing particulate matter - which is amazing to see - we will need to do more tests to see what the long-term performance is for this."GMG is continuing to conduct more tests to determine the total performance regime of the G® Lubricant. These performance tests will be announced as the information becomes available.GMG's Chairman and Director, Jack Perkowski, commented: "Fantastic news - G® Lubricant testing data are exciting - well done to the team - showing great promise as a way to reduce fuel costs and emissions across the multi-trillion dollar liquid fuels industry."About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the potential of G® Lubricant to optimize efficiency and power for stationary or mobile engines, the potential of G® Lubricant to reshape the future of the global liquid fuels industry, GMG's intention to commercialise and market G® Lubricant, the progress of the Company's patent applications, the potential market for G® Lubricant and the potential revenue available for G® Lubricant.Such forward-looking statements are based on a number of assumptions of management, including, without limitation that G® Lubricant has the potential to optimize efficiency and power for stationary or mobile engines, that G® Lubricant has the potential to reshape the future of the global liquid fuels industry, that GMG will commercialize and market G® Lubricant, that the Company's patent applications will progress as anticipated, and that the potential market and revenue available for G® Lubricant will be as currently forecasted. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that G® Lubricant will not offer an innovative solution that optimizes efficiency and power for stationary or mobile engines, that G® Lubricant will not reshape the future of the global liquid fuels industry, that GMG will commercialize and market G® Lubricant as anticipated, that the Company's patent applications will not progress as currently anticipated, that the potential market and revenue available for the G® Lubricant product is not as currently calculated, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/253490 Copyright 2025 ACN Newswire via SeaPRwire.com.

「国际医疗健康周」今日揭开序幕

- 论坛匯聚超过80位全球医疗衞生领域的政府官员及组织、科研先驱、投资者及企业领袖,共同探讨医疗科技、银髮健康、医健体系等方面的国际合作前景;首设「银髮健康专章」,聚焦应对人口老化- 阿兹海默基因研究之父John Hardy教授、2024-2025年亚太经合组织健康工作组主席Victor Yosef Melt Campos医生及世界衞生组织驻华代表Martin Taylor等星级嘉宾亲临论坛,分享最新医疗创新发展- 香港国际医疗及保健展聚焦领先医疗技术、乐龄科技及绿色方案三大范畴,网罗世界最新医疗健康器械、产品和应用方案,包括不少应用了AI人工智能的方案- 医疗展吸引13个国家及地区、约300家展商齐聚一堂,来自英国、泰国及以色列的展团,以及新加坡、德国、意大利和卢森堡的展商首度参展香港,2025年5月27日 - (亚太商讯 via SeaPRwire.com) - 由香港贸易发展局(香港贸发局)策动的「国际医疗健康周」今日隆重开幕,重点旗舰活动之一第五届「亚洲医疗健康高峰论坛」(ASGH)在今明两日(5月26至27日)假湾仔香港会议展览中心盛大举行,以「全球协作 共创未来」(Fostering Global Collaboration for a Shared Future)为主题,匯聚超过80位来自世界各地的医疗领袖与专家,共同探讨行业未来发展方向与合作机遇。另一旗舰活动第16届「香港国际医疗及保健展」(医疗展)亦于同日展开(5月26至28日),匯聚约300家来自13个国家及地区的参展商,聚焦领先医疗技术、乐龄科技及绿色方案,包括不少应用了AI人工智能的方案,促进环球业界合作。论坛开幕环节由香港贸发局主席林建岳博士致欢迎辞,他表示:「当前全球医疗健康领域正面对多项挑战,涵盖下一波传染病大流行、人口老化带来的医疗需求以及健康公平等议题。这些问题极需全球社会共同关注与协作,以保障世界各地社群的健康福祉。踏入第五届,『亚洲医疗健康高峰论坛』已成为全球医疗业界的瞩目盛事,成功促成多个医疗创新的投资与合作项目,令我们引以为傲。同期举办的『香港国际医疗及保健展』,云集全球最新医疗科技方案,包括医院仪器、復康及长者护理用品和生物科技等。作为『国际医疗健康周』的旗舰活动,论坛与医疗展将进一步彰显香港致力与各界携手,推动创新医疗健康产业发展。」香港特别行政区行政长官李家超致开幕辞时表示:「本届论坛以『全球协作 共创未来』为主题,再次肯定香港作为区域医疗创新枢纽的关键角色。『一国两制』下,香港与中国内地及全球保持独特联繫。作为全球最自由经济体及三大国际金融中心之一,我们提供高效、开放与公平的营商环境,并拥有健全的知识产权保护制度。我们维持资讯、资金、货物与人才自由流动。香港亦正积极发展为科学创新、技术发展与国际教育枢纽。」国家衞生健康委员会副主任曹雪涛院士发表特别致辞时指出:「中国推动医疗领域有序、扩大开放、以及稳步推进外商独资医院试点,引进中外合适、合资、合作的高水平医院资源。希望外资企业加快本土化进程,推进中高端产品本土化升级,实现合作共赢 。」此外,大会亦邀得世界衞生组织总干事谭德塞博士在论坛开幕环节发表视像致辞,他表示:「今年论坛的主题贴合全球公共衞生正面临的挑战。世衞近日通过谈判歷时三年半的《大流行协定》,体现全球衞生领域真正的国际合作精神。共同威胁需要共同责任,透过共同努力,我们可以为所有人建立一个更健康、更安全、更公平的世界。」匯聚各国星级行业领袖 共商全球协作机遇今日的「主题环节I - 塑造更公平及可持续的医疗体系」,由香港特别行政区政府医务衞生局局长卢宠茂教授及中华人民共和国工业和信息化部消费品工业司一级巡视员冯海沧发表特别致辞,卢宠茂教授表示:「构建可持续医疗体系需要人才和充足的医疗人力。政府已通过多管齐下的策略应对人力短缺问题,包括增加本地大学的招生名额、吸纳合资格的非本地培训医护人员。此外,2024年施政报告宣佈,政府支持设立第三间医学院的计划。事实上,香港已拥有两间跻身全球前30的顶尖医学院,但我们既有能力,亦有需要发展第三间医学院。该医学院将採取创新的战略定位,与现有两间医学院实现优势互补,共同推动医疗教育与产业发展。」及后的讨论环节由香港大学教研发展基金主席徐立之教授主持,聚焦医疗体系在应对全球挑战所面对的关键问题,由世界衞生组织驻华代表Martin Taylor及香港科技大学校长叶玉如教授等嘉宾,分享宝贵经验与前瞻见解,为全球医疗领域提供启发。叶玉如教授指出:「大学不仅是学术机构,更是连结全球的中立平台及创新的引擎,其独特地位能跨越学科、产业与国家之间的鸿沟。」「主题环节II - 全球协作 共创未来」获多位国际重量级嘉宾出席,包括曾担任日本首相官邸内阁府特别顾问的DEFTA Partners集团主席兼行政总裁原丈人等,共同探讨全球医疗健康合作趋势,为建构更具协同效应的全球医疗格局注入新思维。在「与环球医疗衞生专家对谈」,大会邀得英国伦敦大学学院(UCL)皇后广场神经学研究院神经疾病分子生物学讲座教授,并享有「阿兹海默基因研究之父」美誉的国际知名神经遗传学家John Hardy教授,分享对阿兹海默症等神经退行性疾病未来研究和治疗的展望,他表示:「关于阿兹海默症治疗,我认为有两大进展可能很快便实现:一是提升早期诊断准确度,二是开发能绕过血管类淀粉蛋白的新药。在药物研发方面,我们致力延缓病情恶化。若能釐清导致恶化的根本机制,就能找到治疗的方法,目前已有令人振奋的新发现。」「健康中国2030」是中国国民健康相关政策的规划蓝图,在「实现『健康中国2030』与医健产业高质量发展」中,江苏恒瑞医药股份有限公司执行副总裁张连山博士及默克集团全球执行副总裁兼默克中国总裁何慕麒等嘉宾,一同探讨内地医疗市场发展机遇,剖析国内医疗创新生态系统的发展趋势,为国际合作开闢新途径。多元议题匯聚前瞻洞见 银髮健康专章探索新商机大会首次与香港科技大学合办以「创造医疗新未来」为题的两场专题环节,伦敦帝国学院医学院副院长(研究)Graham Cooke教授等嘉宾,聚焦人工智能在医疗领域的潜能,向与会者分享创新科技如何推动医疗新突破。此外,同日的「展望基因及细胞疗法的前景」、「女性健康新焦点」等环节亦紧扣全球医疗发展脉搏。延续今日的深度对话,明日将呈上更精彩的讨论环节。大会今年首设「银髮健康专章」,聚焦应对人口老化。Cedars-Sinai先进老年治疗学中心主任James L. Kirkland教授等嘉宾将聚首明天上午的「迎接银髮海啸:老年医学与长寿科技的发展」,深入探讨如何应对人口老化所带来的挑战,剖析银髮市场的未来发展趋势与潜在投资机遇。此外,全球知名的嘉宾明日将亲临现场,分享宝贵经验及真知灼见。养和医疗集团营运总监李维文及法国国家公立医院研究委员会(CNCR)总裁Karim Asehnoune教授等嘉宾将在「医健产业未来协作新模式」剖析如何透过多方持份者的协作,推动医健产业的可持续发展。而上海中医药大学首席教授兼中药学院名誉院长徐宏喜教授等嘉宾,亦将于「中西医药结合促进全球健康」讨论中西医药结合的最新发展与商业潜力。同时,「下一波神经科学创新趋势」、「如何利用数据化医疗重塑病人旅程」、「癌症治疗新方向」等多个环节亦将陆续登场。全球医健资源对接平台 创新合作新机遇除专题讨论,论坛亦致力促进与会者洽谈合作,例如环球投资项目对接环节,透过线上或线下一对一会议,为全球各地医健领域的投资者及项目拥有人搭建国际合作与投资桥樑。ASGH亦设立ASGH Business Hub展览专区,云集超过170个来自澳洲、泰国、上海及厦门等13个国家及地区的创新科技企业和获奖项目。其中InnoHealth Showcase展区作为探索商机和创新方案的平台,集合逾70家由创新科技署连同数码港及六家本地大学牵头组织的企业和项目,围绕医药与治疗、智能医疗、医疗器械与诊断,以及社区健康与保健四大重点类别。展区中不少项目聚焦应对人口老化问题,以作「银髮健康专章」的展览环节,如阿兹海默症的早期血液检测技术等,展现出长者医疗方面的前沿实力与潜在机遇。融匯全球顶尖科技成果 全面展示医健产业未来由香港贸发局主办、香港医疗及保健器材行业协会协办的第16届香港国际医疗及保健展同步于今日揭幕,以「智慧医健 创新体验」为主题,聚焦领先医疗技术、乐龄科技及绿色方案三大范畴,网罗世界最新医疗健康器械、产品和应用方案。在领先医疗技术方面,英国展团的London Medical Exchange(展位号码: 3F-H15 )带来全自动人工智能患者监测系统,藉以改善患者护理,将医疗从被动应对转变为主动预防。而香港大学公共衞生学院研究团队成立的卓匯生物科技(展位号码: 3F-G04),带来了「唿吸类器官平台」,可以透过採集个别人士鼻咽或咽喉唾液样本,预测一旦感染唿吸道病毒后,身体将作出甚么反应,让医护更精准用药。乐龄科技方面,香港科技园展团的医念科技(展位号码: 3F-G04),展出认知障碍评估应用程式,透过让中老年人使用电子仪器打麻雀等,以人工智能进行评估及提供个人化脑部训练,帮助他们预防和及早发现患上认知障碍,系统亦可以为患者监测病情。首次参展的香港社会服务联会亦将带来乐龄科技和产品,涵盖的范畴包括復康及行动辅助、支援认知障碍患者和照顾者,及智能家居。社联还会在展会介绍其乐龄科技教育及租赁服务,以及供大众认识和租用乐龄科技的网上平台,让长者、復康人士、照顾者等人士体验使用乐龄科技产品,及按需要租用或购买,过程中跨专业团队会提供支援。社联希望藉展会吸引其他商家协作,扩展服务,令更多市民受惠。绿色方案方面,同属香港科技园展团的MassPhoton(展位号码: 3F-H18)展示结合半导体技术和智能控制技术的紫外光消毒系统,可以更有效、更节能地为空气、水和物件表面消毒。今年医疗展吸引来自13个国家及地区、约300家展商齐聚一堂,当中英国、泰国及以色列的展团,以及新加坡、德国、意大利和卢森堡的展商首度参与,亦有七家香港本地大学、香港科技园展团率领的逾30家创科企业,及香港医疗及保健器材行业协会带来的逾20家医疗企业参展,展示本地创新实力。展览设有多个专题展区,包括:生物科技、医院仪器、復康及长者护理用品、初创专区,和香港医疗及保健器材行业协会专属展区等,焦点展品包括人工智能康復系统、便携式超声诊断系统及智慧医院机器人等多项前沿科技成果。医疗展期间亦设有多元化活动,包括论坛、研讨会及交流酒会等。明天会有两场以大湾区医疗为主题的论坛,上午由香港医疗及保健器材行业协会协办的论坛「大湾区的医疗科技枢纽」邀请多位业界专家,分享生物医药创新的知识产权策略、如何整合资源以开发大湾区医疗科技市场,及在大湾区推广医疗科技的成功经验等。下午的「粤港澳大湾区医疗器械监管与协作发展」论坛,将由国家药品监督管理局医疗器械技术审评检查大湾区分中心、衞生署疗器械科及通标标准技术服务的专家,共同探讨相关领域的最新发展、管理制度和法规,促进区域间的监管协作与创新交流。今届展览将继续沿用「EXHIBITION+」(展览+)模式举行,除了实体展览,环球展商、业界人士和买家亦可透过「商对易」(Click2Match)智能商贸配对平台进行洽商,直至 6月 4日,以促成更多合作。除了亚洲医疗健康高峰论坛和香港国际医疗及保健展,「国际医疗健康周」亦包含2025年医院管理局研讨大会等其他精彩活动。图片下载:https://bit.ly/43xCK2b香港特别行政区政府及香港贸易发展局主办的第五届「亚洲医疗健康高峰论坛」于5月26至27日假香港会议展览中心举行,并以「全球协作 共创未来」作为主题。香港贸发局主席林建岳博士致欢迎辞。香港特别行政区行政长官李家超致开幕辞。国家衞生健康委员会副主任曹雪涛院士发表特别致辞。世界衞生组织总干事谭德塞博士在开幕环节发表视像讲话。论坛邀请到英国伦敦大学学院(UCL)皇后广场神经学研究院神经疾病分子生物学讲座教授,曾获颁生命科学突破奖以及大脑研究奖并享有「阿兹海默基因研究之父」美誉的国际知名神经遗传学家John Hardy教授作为专题演讲嘉宾。环球投资项目对接环节透过线上或线下一对一会议,为全球各地医疗保健领域搭建国际合作与投资桥樑。论坛促成多项合作协订,开展更多医健产业内不同领域的具体合作。第16届香港国际医疗及保健展(医疗展)以「智慧医健 创新体验」为主题,聚焦领先医疗技术、乐龄科技及绿色方案三大范畴,网罗世界最新医疗健康器械、产品和应用方案。香港科技园展团的医念科技,展出认知障碍评估应用程式,透过让中老年人使用电子仪器打麻雀等,以人工智能进行评估及提供个人化脑部训练,帮助他们预防和及早发现患上认知障碍。首次参展的香港社会服务联会带来乐龄科技和产品,涵盖的范畴包括復康及行动辅助、支援认知障碍患者和照顾者,及智能家居。匈牙利展团再度参展,带来评估健康状况的仪器及医疗相关的课程等。相关网页国际医疗健康周:https://internationalhealthcareweek.hktdc.com/sc亚洲医疗健康高峰论坛︰https://www.asiasummitglobalhealth.com/conference/asgh/sc论坛议程︰https://www.asiasummitglobalhealth.com/conference/asgh/sc/programme论坛讲者名单︰https://www.asiasummitglobalhealth.com/conference/asgh/sc/speaker香港国际医疗及保健展:https://www.hktdc.com/event/hkmedicalfair/sc精选产品及详情:https://www.hktdc.com/event/hkmedicalfair/sc/product活动及研讨会议程:https://www.hktdc.com/event/hkmedicalfair/sc/intelligence-hub传媒查询新闻界如有查询,请联络圆通财经公关有限公司:宋柳逸电话:(852) 3428 5691电邮:lsong@yuantung.com.hk梁婉彤电话:(852) 3428 2361电邮:tleung@yuantung.com.hk香港贸易发展局传讯及公共事务部:亚洲医疗健康高峰论坛夏妙婷电话:(852) 2584 4575电邮:sharon.mt.ha@hktdc.org黄家欣电话:(852) 2584 4524电邮:katy.ky.wong@hktdc.org张敏萱电话:(852) 2584 4137电邮:jane.mh.cheung@hktdc.org香港国际医疗及保健展石婉婷电话:(852) 2584 4537电邮:kelly.yt.shek@hktdc.org刘茸电话:(852) 2584 4472电邮:clayton.y.lauw@hktdc.org香港贸发局新闻中心︰http://mediaroom.hktdc.com/tc香港贸易发展局简介香港贸易发展局(香港贸发局)是于1966年成立的法定机构,负责促进、协助和发展香港贸易。香港贸发局在世界各地设有超过50个办事处,其中13个设于中国内地,致力推广本港作为双向环球投资及商业枢纽。 香港贸发局通过举办国际展览会、会议及商贸考察团,为企业(尤其是中小企)开拓内地和环球市场的机遇。香港贸发局亦通过研究报告和数码资讯平台,提供最新的市场分析和产品资讯。有关香港贸发局的其他资讯,请浏览www.hktdc.com/aboutus/tc。 Copyright 2025 亚太商讯 via SeaPRwire.com.

International Healthcare Week kicks off today

- The Asia Summit on Global Health (ASGH) gathers over 80 government officials and organisations, research pioneers, investors, and business leaders to explore international collaboration on medical technology, silver health, and healthcare systems. A dedicated “Silver Health Chapter” debuts this year to spotlight the ageing population.- Renowned speakers include Prof John Hardy, the “father of Alzheimer’s disease genetic studies”; Dr Victor Yosef Melt Campos, Chair (2024-2025) of APEC Health Working Group and General Director of International Cooperation at the Ministry of Health of Peru; and Martin Taylor, Representative to China of the World Health Organization. They will share insights on the latest developments in medical innovation.- The Hong Kong International Medical and Healthcare Fair (Medical Fair) focuses on MedTech, GeronTech, and green solutions, featuring the latest medical health devices, products, and solutions including many AI-powered innovations.- The Medical Fair has attracted some 300 exhibitors from 13 countries and regions. Participating with pavilions for the first time are Israel, Thailand, and the UK, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg.HONG KONG, May 26, 2025 - (ACN Newswire via SeaPRwire.com) – International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), officially opened today. One of its flagship events, the fifth Asia Summit on Global Health (ASGH), takes place today and tomorrow (26 and 27 May) at the Hong Kong Convention and Exhibition Centre (HKCEC). Under the theme Fostering Global Collaboration for a Shared Future, the summit brings together more than 80 healthcare leaders and experts from around the world to explore the future direction of the industry and collaboration opportunities. Another flagship event, the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), also kicks off today (26 to 28 May), and features some 300 exhibitors from 13 countries and regions, showcasing cutting-edge MedTech, GeronTech, and green solutions, including many AI-powered innovations, to foster global industry collaboration.The ASGH opened with welcome remarks delivered by HKTDC Chairman Dr Peter K N Lam.  “The global health sector is currently facing challenges, including a resurgence in infectious diseases, coupled with the growing needs of an ageing population and ongoing health equity concerns. These issues demand urgent attention and collective action to protect communities worldwide. Now in its fifth edition, ASGH is a key event for the global healthcare industry, and we are proud that connections made through ASGH have enabled many new investments and collaborations in healthcare innovation. Alongside ASGH, the Hong Kong International Medical and Healthcare Fair is taking place. There, you will find the latest HealthTech solutions from around the globe, with a particular focus on hospital equipment, rehabilitation, elderly care and biotech. As anchor events of the International Healthcare Week, ASGH and Medical Fair highlights Hong Kong’s commitment to working with partners to nurture an innovative health and medical sector,” Dr Lam said.In his opening speech, Hong Kong SAR Chief Executive John Lee said: "Under the theme of "Fostering Global Collaboration for a Shared Future", this summit reaffirms Hong Kong's pivotal role as a leading health innovation hub in the region. Under the "one country, two systems" principle, Hong Kong enjoys unique connectivity with both Mainland China and the world. As the world's freest economy and one of the top three international financial centres, we offer an efficient, open and fair business environment with robust intellectual property protection. We maintain free flows of information, capital, goods and talent. We are also emerging as a leading hub for scientific innovation, technological advancement and world-class education.”Prof Cao Xuetao, Vice-Minister of the National Health Commission of the People’s Republic of China, gave special remarks, noting: "China continues to open up and welcomes leading foreign-owned hospitals into the market through investment or joint ventures. We hope that our global partners can further localise and upgrade their mid-to-high-end products, resulting in win-win outcomes for all.”Additionally, Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), delivered remarks at the opening session via video link and stated, “The theme of ASGH could not be more appropriate given the challenges facing global health at the moment. The WHO Pandemic Agreement has been adopted recently. It was negotiated over the past three and a half years and shows a true spirit of international collaboration for global health. By working together, we can build a healthier, safer, and fairer world for all.”Global industry leaders gather to explore opportunities for international collaborationToday's Plenary Session I: Shaping a More Equitable and Sustainable Health System, featured keynote remarks by Prof Lo Chung-mau, Secretary for Health of the HKSAR Government, and Feng Haicang, Level I Bureau Rank Official of Department of Consumer Goods Industry, Ministry of Industry and Information Technology of the People's Republic of China.  Prof Lo Chung-mau, stated: “A sustainable health system requires talents and enough healthcare manpower. While the Government has been addressing the issue of manpower shortage through a multipronged strategy, by increasing the number of intakes for local universities and admitting qualified non-locally trained healthcare workers, the 2024 Policy Address announced that the Government supports the plan to establish a third medical school. Indeed, Hong Kong has already hosted two top 30 world class medical schools but we have the ability and the need to develop the third one which shall adopt an innovative strategic positioning in pursuit of complementary development with the two existing ones.” The session was moderated by Prof Tsui Lap-chee, Chairman of the University of Hong Kong Foundation for Educational Development and Research, focused on key issues faced by healthcare systems in addressing global challenges. Distinguished speakers included Martin Taylor, Representative to China of the WHO; and Prof Nancy Ip, President of the Hong Kong University of Science and Technology. They shared valuable experiences and forward-looking insights to inspire the global healthcare field.Prof Nancy Ip noted: “Universities are more than academic institutions. They are global connectors, neutral platforms, and also engines of innovation, uniquely positioned to bridge divides between disciplines, industries, and also nations.”Distinguished international speakers of Plenary Session II: Fostering Global Collaboration for a Shared Future included Ambassador George Hara, Group Chairman and CEO of DEFTA Partners and former Special Advisor to the Cabinet Office of the Prime Minister of Japan. They jointly explored trends in global healthcare collaboration, injecting new ideas into constructing a more synergistic global healthcare landscape.The summit invited Prof John Hardy, known as the “father of Alzheimer’s disease genetic studies”, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, to share his outlook on future research and treatment of neurodegenerative diseases such as Alzheimer's in the Dialogue with Global Pioneer in Health session.Prof John Hardy remarked: “For Alzheimer's treatment, I think that two changes can happen quite quickly: improvements in earlier diagnosis, and development of drugs that bypass the blood vessel-based amyloid. What we want to do with drugs is slow decline. If we understand what underpins that decline, it gives us targets, and we’re very excited by some of the findings in that area now.”“Healthy China 2030” serves as the national blueprint for healthcare policy development in Mainland China. In the session Beyond “Healthy China 2030”: Driving Health Innovation, Dr Zhang Lianshan, Executive Vice President, Jiangsu Hengrui Pharmaceuticals Co., Ltd.; and Marc Horn, Executive Vice President of Merck and President of Merck China, explored opportunities in the mainland healthcare market, analysing emerging trends in China's healthcare innovation ecosystem to open new pathways for international collaboration with other speakers.Diverse topics converge with forward-looking insights and the Silver Health Chapter explores new business opportunitiesFor the first time, the summit co-organised two thematic sessions with the Hong Kong University of Science and Technology under the overarching theme Shaping the Future of Healthcare. Speakers included Prof Graham Cooke, Vice-Dean (Research) of Faculty of Medicine at Imperial College London. They focused on the potential of AI in the medical field, sharing with participants how innovative technologies are driving new breakthroughs in healthcare. Additionally, sessions on Peeking into the Future of Gene and Cell Therapies and Women’s Health in Focus were also closely aligned with global medical development trends.Continuing today's in-depth dialogues, more exciting sessions will be presented tomorrow. For the first time, the summit will feature a Silver Health Chapter focusing on addressing the challenging ageing societies. Speakers including Prof James L. Kirkland, Director of Cedars-Sinai’s Centre for Advanced Gerotherapeutics, will gather at tomorrow morning's session Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology to delve into how to address the challenges brought by an ageing population, analysing future development trends and potential investment opportunities in the silver economy market.Furthermore, globally renowned speakers will be present tomorrow to share their valuable experiences and insights. Wyman Li, Chief Operating Officer of HKSH Medical Group; Prof Karim Asehnoune, President of National Committee for Public Hospital Research (CNCR), and other speakers will analyse how to promote the sustainable development of the healthcare industry through collaboration among different stakeholders in the session, Reinventing the Business of Healthcare through Partnerships. Prof Xu Hongxi, Distinguished Professor and Honorary Dean of Shanghai University of Traditional Chinese Medicine and other guests will discuss the latest developments and commercial potential of integrating Chinese and Western medicine in the session The Convergence of Chinese and Western Medicine in Global Health. Sessions on The Next Wave of Innovations in Neuroscience, Data-driven Healthcare Transforming Patient Journey and The Changing Face of Cancer will also be held tomorrow.A global platform for healthcare resource matchmaking to foster opportunities for innovative collaborationIn addition to thematic discussions, the summit also aims to bridge global collaboration among participants. For example, the ASGH Deal-making facilitates one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations.The summit has established the ASGH Business Hub, which brings together more than 170 innovative technology companies and award-winning projects from 13 countries and regions, including the mainland (Shanghai and Xiamen), Australia, and Thailand. The InnoHealth Showcase serves as a platform to explore business opportunities and innovative solutions and highlights more than 70 healthcare start-ups and projects led by the Innovation and Technology Commission, Cyberport, and six local universities. The showcase is structured around four key categories: pharmaceuticals and therapeutics, AI and Digital Health, medical devices and diagnostics, and community health and wellness. As part of the “Silver Health Chapter”, some of the showcased projects address the challenges of an ageing population, including early blood tests for Alzheimer’s disease, demonstrating cutting-edge capabilities and market potential in elderly healthcare.Integrating global innovations to showcase the future of healthcareThe Hong Kong International Medical and Healthcare Fair also opened today, organised by the HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA). Under the theme Innovations Boosting Smart Health Experience, this year’s Fair focuses on three key areas: MedTech, GeronTech and green solutions, featuring the latest medical health devices, products, and solutions.In the field of MedTech, UK exhibitor London Medical Exchange (Booth No: 3F-H15) presents a fully automated AI-powered patient monitoring system designed to improve patient care, transforming healthcare from reactive to proactive. Meanwhile, C2iTech (Booth No: 3F-G04), established by a research team from the School of Public Health at The University of Hong Kong, showcases a Respiratory Organoid Platform (ROP). By analysing nasopharyngeal or throat saliva samples from individuals, the platform predicts their likely response to respiratory virus infections, enabling more precise and personalised treatment by healthcare professionals.In the GeronTech segment, Medmind Technology (Booth No: 3F-G04), from the Hong Kong Science and Technology Parks Corporation (HKSTP) Pavilion, introduces an app for cognitive impairment assessment. The tool allows middle-aged and elderly users to play digital mahjong and other games, with AI used to assess their cognitive status and offer personalised brain training, helping prevent and detect early signs of cognitive decline. The system can also monitor patient conditions over time.The Hong Kong Council of Social Service (HKCSS), participating in the fair for the first time, is showcasing a range of GeronTech and related products, covering areas such as rehabilitation and mobility assistance, cognitive impairment support for patients and carers, and smart home solutions. HKCSS is also introducing its GeronTech education and rental services, along with its online platform that enables the public to learn about and hire GeronTech equipment. Users such as the elderly, people in rehabilitation, and carers can try out products, and rent or purchase them as needed, with support from a cross-disciplinary professional team. Through the Medical Fair, HKCSS aims to attract collaboration with other businesses to expand its services and benefit a wider segment of the community.For green solutions, MassPhoton (Booth No: 3F-H18), also from the HKSTP Pavilion, presents an ultraviolet disinfection system that combines semiconductor and smart control technologies, delivering more efficient and energy-saving disinfection for air, water and surfaces.This year’s Medical Fair has attracted some 300 exhibitors from 13 countries and regions. Participating with pavilions for the first time are Israel, Thailand, and the UK, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg. Highlighting Hong Kong’s strength in medical innovation, seven local universities, over 30 innovative technology companies at the HKSTP pavilion, and more than 20 medical enterprises brought by the HKMHDIA are participating.The exhibition features a range of thematic zones, including Biotechnology, Hospital Equipment, Rehabilitation and Elderly Care Products, and Start-up and HKMHDIA zones.  Highlight exhibits include AI-powered rehabilitation systems, portable ultrasound diagnostic systems, and smart hospital robots, demonstrating the frontiers of medical and healthcare technology.During the Medical Fair, there will be forums, seminars and networking receptions. Two forums focused on the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) healthcare sector will take place tomorrow. The morning forum titled The MedTech Nexus of the Greater Bay Area, which is co-organised with the HKMHDIA, will feature industry experts sharing insights on intellectual property strategies for biomedical innovation, ways to integrate resources for GBA market development, and successful experiences in promoting medical technology in the GBA. The afternoon forum titled The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area will bring together experts from the Greater Bay Area Centre for Medical Device Evaluation and Inspection of National Medical Products Administration, the Medical Device Division of Department of Health, and SGS-CSTC Standards Technical Services Co., Ltd., to explore the latest developments, administrative systems and regulations in relevant fields, promoting cross-regional regulatory collaboration and fostering innovation through idea exchange.Using the HKTDC EXHIBITION+ hybrid model, global exhibitors, industry professionals, and buyers can continue business matching via the Click2Match smart business matching platform until 4 June, encouraging more cooperation.Aside from ASGH and the Medical Fair, IHW also features the Hospital Authority Convention, among many other industry events.Photo download: https://bit.ly/43xCK2bThe fifth Asia Summit on Global Health, jointly organised by the Hong Kong SAR Government and the Hong Kong Trade Development Council takes place at the Hong Kong Convention and Exhibition Centre from 26 to 27 May 2025 under the theme Fostering Global Collaboration for a Shared FutureDr Peter K N Lam, HKTDC Chairman, gives a welcome addressJohn Lee, Chief Executive of the Hong Kong SAR, delivers opening remarksProf Cao Xuetao, Deputy Director of the National Health Commission of the People’s Republic of China, delivers special remarksDr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation, delivers remarks at the opening session via video linkThe summit invites Prof John Hardy, Chair of Molecular Biology of Neurological Disease at UCL Queen Square Institute of Neurology. As an internationally renowned neurogeneticist, and Brain Prize recipient for "groundbreaking research on the basis of Alzheimer's disease", Prof John Hardy is known as the “father of Alzheimer’s disease genetic studies”ASGH deal-making facilitates one-on-one meetings both online and offline, aiming to bridge investors with healthcare projects from around the world and promote global collaborationASGH facilitates the signing of the partnership agreements, fostering concrete collaboration in various areas of the healthcare industry.The 16th Hong Kong International Medical and Healthcare Fair, themed Innovations Boosting Smart Health Experience, focuses on three key areas: MedTech, GeronTech and green solutions, featuring the latest medical health devices, products, and solutionsMedmind Technology, from Hong Kong Science and Technology Parks Corporation (HKSTP) Pavilion, introduces an app for cognitive impairment assessment. The tool allows middle-aged and elderly users to play digital mahjong and other games, with AI used to assess their cognitive status and offer personalised brain training, helping prevent and detect early signs of cognitive declineThe Hong Kong Council of Social Service (HKCSS), participating in the fair for the first time, showcases a range of GeronTech products, covering areas such as rehabilitation and mobility assistance, cognitive impairment support for patients and carers, and smart home solutionsThe Hungarian pavilion is once again participating in the Medical Fair, bringing devices for health assessment and medical-related coursesWebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enAsia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/enProgramme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programmeSpeakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speakerHong Kong International Medical and Healthcare Fair:https://www.hktdc.com/event/hkmedicalfair/enList of products: https://www.hktdc.com/event/hkmedicalfair/en/productActivity schedule: https://www.hktdc.com/event/hkmedicalfair/en/intelligence-hubMedia enquiriesFor enquiries, please contact Yuan Tung Financial Relations Limited:Louise SongTel: (852) 3428 5691Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Asia Summit on Global HealthSharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgHong Kong International Medical and Healthcare FairKelly ShekTel: (852) 2584 4537Email: kelly.yt.shek@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.com Copyright 2025 ACN Newswire via SeaPRwire.com.

V4 Industry Leaders to Gather in Bratislava to Discuss Transatlantic Trade and EU Market Strategies

BRATISLAVA, May 26, 2025 - (ACN Newswire via SeaPRwire.com) - The Council of Slovak Exporters welcomes the launch of the European Commission’s public consultation, announced in early May, focused on potential response measures regarding certain imported goods from the United States, should ongoing discussions on transatlantic economic cooperation not lead to a mutually beneficial outcome. Topics under consultation may include trade flows in sectors such as steel scrap and chemical products. The consultation will close on 10 June, coinciding with the Visegrad 4 Business Conference in Bratislava, where regional business leaders will convene to address global economic relations, EU market resilience, and other key issues critical to regional competitiveness."It is indeed symbolic that these consultations with the European Commission, which represent a much-needed link between the private and public sectors, are culminating on the day of our Visegrad 4 Business Conference, which aims to do exactly the same: To achieve demand-driven public policies and measures that will help Europe's industry and exports from losing global competitiveness." – said Lukáš Parízek, founder of the Visegrad 4 Business Conference and Chairman of the Council of Slovak Exporters.Top industry representatives from various sectors, as well as public officials and representatives of foreign diplomatic missions, have already confirmed their participation in this key regional business event. The conference, organized in the premises of the Bratislava Castle, will be opened with a speech by the Speaker of the Parliament Richard Raši. Maros Sefcovic, European Commissioner for Trade and Economic Security, will deliver his remarks and speak in an exclusive format during the first part of the day, as well as attend a roundtable discussion with industry leaders from the V4 region. Slovak Foreign Minister Juraj Blanár and Hungarian Foreign Minister Péter Szijjártó have also confirmed their participation in the closing part of the conference.Visegrad 4 Business Conference is jointly organised since 2022 by four business organisations from the V4 region: Council of Slovak Exporters, Czech Association of Exporters, Hungarian business association MAPI Klub and Polish Economic Forum. The conference is organised with the support of the International Visegrad Fund, individual V4 governments and private sponsors.For more information visit www.visegrad4business.eu.About the Council of Slovak ExportersThe Council of Slovak Exporters was established in 2020 as a response to COVID-19's impact on local businesses. With over 130 supporting companies, this business platform connects exporters and facilitates dialogue with state institutions, international organizations, and financial institutions. The Council publicly communicates in support of Slovak exporters, provides export-related assistance, organizes networking events, and connects relevant entities in international trade. The organization holds BRONZE "European Cluster Excellence Initiative" certification, operating at the European level.Social LinksX: https://x.com/Visegrad4BInstagram: https://www.instagram.com/visegrad4business/LinkedIn: https://www.linkedin.com/company/visegrad-4-business/Facebook: https://www.facebook.com/visegrad4business#Media ContactCouncil of Slovak ExportersVisegrad 4 Business Conference+421 914 201 101https://www.visegrad4business.eu/ Copyright 2025 ACN Newswire via SeaPRwire.com.

CBL International Limited Announces Name Change of Singapore Subsidiary to Support Regional Growth Strategy

Kuala Lumpur, May 26, 2025 - (ACN Newswire via SeaPRwire.com) – CBL International Limited (NASDAQ: BANL) (“CBL” or the “Company”), the listing vehicle of Banle Group (“Banle” or the “Group”), a leading marine fuel logistics company in the Asia-Pacific region, today announced the official renaming of its Singapore-based wholly owned subsidiary, Majestic Energy (Singapore) Pte Ltd, to support its regional growth strategy.Effective immediately, Majestic Energy (Singapore) Pte Ltd has been officially renamed to Banle International (Singapore) Pte Ltd, reflecting the Group’s deepening commitment to the Singapore market and its strategic expansion into sustainable fuels.Singapore remains the world's largest bunkering hub, with annual sales close to 55 million metric tons in 2024, increased by 6% year-over-year as compared to 2023, according to Maritime & Port Authority of Singapore (“MPA”) statistics. While conventional fuels still dominate the market, demand for sustainable fuels such as biofuels, LNG, and methanol continues to rise steadily. Notably, biofuel sales in the first four months of 2025 in Singapore have already surpassed 50% of the total volume recorded in 2024, according to  MPA statistics.As the primary fuel bunkering hub in the Asia-Pacific region, Singapore serves as a strategic base for CBL’s regional expansion. CBL’s revenue in Singapore increased by 102% year-over-year in 2024 as compared to 2023. In March 2025, the Company launched its first biofuel supply services in Singapore — a key regional port — as part of its broader initiative to offer sustainable fuel alternatives across the region, followed by biofuel supply in Malaysia, Hong Kong and various ports in China. CBL’s biofuel sales volumes and sales surged over 600% year-over-year in 2024, supported by strengthened supplier relationships and reliable supply chains. These efforts help customers meet IMO GHG targets while offering sustainable, cost-effective alternatives.“Singapore plays a pivotal role in our long-term growth strategy,” said Dr. Teck Lim Chia, Chairman and CEO of CBL. “The renaming of our subsidiary underscores our strengthened presence in this critical market and reinforces our commitment to supporting the global maritime industry’s transition toward greener energy solutions.”Despite the increasing competition in Singapore’s bunkering sector, CBL continues to differentiate itself through its agile operations and customer-centric approach. The Company prides itself on its ability to adapt and tailor solutions to meet the specific needs of clients and suppliers, enabling it to capture new opportunities in both traditional and emerging fuel segments.Christofel Tian, our Head of Singapore, added "With our rebranding to Banle International (Singapore) Pte Ltd, we are not only aligning ourselves more closely with the Group’s identity but also signaling our long-term commitment to the Singapore market. As the global bunkering landscape evolves, especially with the rapid adoption of sustainable fuels, we are well-positioned to grow alongside Singapore’s vision of becoming a leader in sustainable maritime solutions."With its robust regulatory environment, mature infrastructure, and strong government support, Singapore is well-positioned to maintain its leadership in the global bunkering market — and CBL is committed to growing alongside it.About the Banle GroupCBL International Limited (Nasdaq: BANL) is the listing vehicle of Banle Group, a reputable marine fuel logistic company based in the Asia Pacific region that was established in 2015. We are committed to providing customers with one-stop solution for vessel refueling, which is referred to as bunkering facilitator in the bunkering industry. We facilitate vessel refueling mainly through local physical suppliers in over 60 major ports covering Belgium, China, Hong Kong, India, Japan, Korea, Malaysia, Mauritius, Panama, the Philippines, Singapore, Taiwan, Thailand, Turkey and Vietnam, as of 16 April 2025. The Group actively promotes the use of sustainable fuels and is awarded with the ISCC EU and ISCC Plus certifications.For more information about our company, please visit our website at: https://www.banle-intl.com.Forward-Looking StatementsCertain statements in this announcement are not historical facts but are forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “could,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan,” “should,” “would,” “plan,” “future,” “outlook,” “potential,” “project” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other performance metrics and projections of market opportunity. They involve known and unknown risks and uncertainties and are based on various assumptions, whether or not identified in this press release and on current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. Some important factors that could cause actual results to differ materially from those in any forward-looking statements could include changes in domestic and foreign business, markets, financial, political and legal conditions, geopolitical disruptions and other events that result in material changes in fuel prices. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.CBL INTERNATIONAL LIMITED (Incorporated in Cayman Islands with limited liabilities)For more information, please contact: CBL International Limited Email: investors@banle-intl.comStrategic Financial Relations LimitedShelly Cheng        Tel: (852) 2864 4857 Iris Au Yeung       Tel: (852) 2114 4913 Email:              sprg_cbl@sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

CBL International Limited宣布更名新加坡子公司 以支持区域增长战略

吉隆坡,2025年5月26日 - (亚太商讯 via SeaPRwire.com) - CBL International Limited(纳斯达克代码:BANL)("CBL"或"公司"),万利集团("万利"或"集团")旗下的上市平台,是一家领先的亚太地区船用燃料物流公司,今日宣布正式更名其位于新加坡的全资子公司Majestic Energy (Singapore) Pte Ltd,以支持其区域增长战略。自即日起, Majestic Energy (Singapore) Pte Ltd 正式更名为 Banle International (Singapore) Pte Ltd ,反映出集团对新加坡市场的深入承诺,以及向可持续燃料领域扩展的战略方向。根据新加坡海事及港务管理局(MPA)的数据,新加坡仍是全球最大的船用燃料加注枢纽,2024年的年销售量接近5,500万吨,较2023年同比增长6%。尽管传统燃料仍占据市场主导地位,但生物燃料、液化天然气(LNG)和甲醇等可持续燃料的需求持续稳步上升。尤其值得注意的是,根据新加坡海事及港务管理局统计,2025年前四个月的新加坡生物燃料销量已超过2024年全年总量的一半。作为亚太地区主要的燃料加注枢纽,新加坡是CBL区域扩张的重要战略基地。2024财年,CBL在新加坡的收入同比2023财年增长了102%。继于马来西亚、香港及中国多个港口开展生物燃料供应业务,2025年3月,公司在新加坡这一关键区域港口启动了首次生物燃料供应服务,作为其在整个区域提供可持续替代燃料更广泛计划的一部分。受供应商关系强化与供应链稳定的支持,CBL的2024年生物燃料销售量和销售额实现了同比增长超600%,助力客户实现国际海事组织(IMO)温室气体(GHG)减排目标,同时提供可持续且具有成本效益的替代方案。"新加坡在我们的长期发展战略中扮演着关键角色,"集团主席兼行政总裁谢威廉博士表示。"此次子公司的更名彰显了我们在这一关键市场实力的增强,并重申我们支持全球航运业向绿色能源转型的承诺。"尽管新加坡的燃料加注行业竞争日益激烈,CBL仍凭借灵活的运营模式和以客户为中心的服务理念脱颖而出。公司自豪于能够根据客户和供应商的具体需求定制解决方案,从而在传统和新兴燃料领域中把握新机遇。新加坡区域主管田祥福先生补充道:"随着我们品牌升级为Banle International (Singapore) Pte Ltd,我们不仅更加贴近集团的整体品牌形象,也进一步表明了我们对新加坡市场的长期承诺。随着全球燃料加注格局的发展,特别是在可持续燃料快速采用的背景下,我们已做好充分准备,与新加坡成为可持续海事解决方案领导者的愿景共同成长。"凭借健全的监管环境、成熟的基础设施以及强大的政府支持,新加坡具备持续引领全球燃料加注市场的条件,而CBL也将坚定地与其一同成长。前瞻性声明本公吿中的某些陈述并非历史事实,而是前瞻性陈述。前瞻性陈述一般使用"相信"、"可能"、"可以"、"将要"、"估计"、"继续"、"预期"、"打算"、"期望"、"计划"、"应该"、"将会"、"规划"、"未来"、"展望"、"潜力"、"预测"等类似词语来预测或表达未来事件或趋势或不属于历史事项的陈述,但不使用这些词语并不意味著陈述并非前瞻性。这些前瞻性陈述包括但不限于对其他绩效指标的估计和预测,以及对市场机会的预测。这些信息涉及已知和未知的风险和不确定性,并基于各种假设(无论本新闻稿中是否指明)以及BANL管理层的当前预期,而非对实际业绩的预测。这些前瞻性陈述仅供帮助目的,不得被任何投资者作为且不得被依赖为对事实或可能性的担保、保证、预测或确凿陈述。实际事件和情况难以或不可能预测,也会与假设不同。许多实际事件和情况不在BANL的控制范围内。一些重要因素可能导致实际结果与任何前瞻性陈述存在实质性差异,包括国内外商业、燃料价格和关税、市场、金融、政治、法律环境、地缘政治及其他导致燃料价格发生重大变化的事件的影响。公司没有义务公开更新或修改任何前瞻性陈述来反映随后发生的事件或情况或预期的变化,法律可能要求者除外。尽管公司认为该等前瞻性陈述中表达的预期合理,但不能向您保证此类预期最终正确无误。公司提醒投资者实际结果可能与预期结果存在重大差异,并鼓励投资者细阅公司的注册声明和向SEC提交的其他文件所载可能影响其未来业绩的其他因素。关于万利集团万利集团成立于 2015 年,以CBL International Limited(纳斯达克:BANL)在纳斯达克股票市场上市。我们致力于为客户提供一站式燃油供应服务,被业内称为燃油供应服务商。截至2025年4月 16日,我们主要通过当地实体供货商为船舶提供燃油加注服务,遍布比利时、中国、香港、印度、日本、韩国、马来西亚、毛里裘斯、巴拿马、菲律宾、新加坡、台湾、泰国、土耳其和越南,共覆盖超过60个港口。集团积极推动可持续燃料,并已取得ISCC EU和ISCC Plus认证。如欲了解更多信息,请到集团网站 https://www.banle-intl.com 浏览。如需更多资讯,请联系:CBL International Limited电邮:investors@banle-intl.com纵横财经公关顾问有限公司郑松雪 电话:(852) 2864 4834欧阳蔚雯 电话:(852) 2114 4913电邮:sprg_cbl@sprg.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com.

Ensign InfoSecurity Wins “Cybersecurity Product of the Year” at Tech Fest Hong Kong Awards

AI-powered real-time deepfake detection solution, Aletheia, recognised for effectiveness, innovation, and operational scalabilityHONG KONG, May 27, 2025 - (ACN Newswire via SeaPRwire.com) - Ensign InfoSecurity (“Ensign”), one of Asia’s largest cybersecurity service providers, has won the “Product Excellence - Cybersecurity Product of the Year” award at the Tech Fest Hong Kong Awards 2025 for its proprietary solution, *Aletheia, an AI-powered real-time deepfake detection tool that enhances digital trust and protects organisations against multimedia-based deception.Developed by Ensign Labs, Aletheia uses multi-modal artificial intelligence to identify manipulated video and audio content. Available across endpoint software or a chrome browser plug-in, the solution delivers real-time detection to support secure virtual meetings, digital identity verification, and high-assurance communication environments.Built for operational environments, Aletheia performs all detection on-device, ensuring privacy-first analysis without cloud dependency. It integrates seamlessly with Security Information and Event Management (SIEM) systems to provide real-time alerts, enabling security teams to respond swiftly with forensic-ready evidence for investigation and resolution.“This award reinforces the purpose behind our work,” said Nicky Au, General Manager, Greater China Region, Ensign InfoSecurity (East Asia) Limited. “As threats grow more sophisticated, the ability to safeguard digital interactions, authentically and at speed, has become critical to business resilience and public trust.Cybersecurity is not achieved in isolation. It requires coordination, transparency, and shared intelligence. At Ensign, we are committed to working alongside our peers, partners, and clients to stay ahead of what’s next.”Aletheia is built to meet the evolving needs of sectors most vulnerable to digital deception. Examples of its use are varied. In financial services, it adds a line of defence during voice authentication and transaction validation. For media organisations, it supports source verification and editorial integrity. Government agencies can rely on it to validate emergency communications, while Human Resource departments use it to screen for audio-visual fraud in remote interviews and recruitment processes.This award underscores Ensign’s commitment to developing applied, scalable technologies through its in-house R&D. Aletheia is part of a broader portfolio of AI-powered capabilities that include cyber analytics, digital risk monitoring, and automated threat detection, designed to equip enterprises and public institutions with future-ready defence strategies.*Aletheia, in Greek mythology, refers to the Goddess of truth, symbolising the pursuit of truth and transparency.About Ensign InfoSecurityEnsign InfoSecurity is the largest cybersecurity service provider in Asia. Headquartered in Singapore, Ensign offers bespoke solutions and services to address their clients’ cybersecurity needs. Their core competencies are in the provision of cybersecurity advisory and assurance services, architecture design and systems integration services, and managed security services for advanced threat detection, threat hunting, and incident response. Underpinning these competencies is in-house research and development in cybersecurity. Ensign has two decades of proven track record as a trusted and relevant service provider, serving clients from the public and private sectors in the Asia Pacific region.For more information, visit www.ensigninfosecurity.com, or email media@ensigninfosecurity.com Copyright 2025 ACN Newswire via SeaPRwire.com.

Eastern River to Introduce Bond ETFs and Launch a New Fixed-Income Fund to Broaden Investment Offering

ADELAIDE, AUS, May 26, 2025 - (ACN Newswire via SeaPRwire.com) - Eastern River, a leading Australian bond brokerage, is set to expand its investment platform with the introduction of Bond Exchange-Traded Funds (ETFs) and the upcoming launch of a new fixed-income fund. These developments represent a significant step forward in improving access to institutional-grade bond strategies for both private and wholesale investors.The addition of Bond ETFs will provide clients with an efficient and liquid route to diversified fixed-income exposure, encompassing government, corporate, and ESG-focused debt instruments. This move reflects Eastern River's continued commitment to delivering cost-effective, transparent solutions in a dynamic yield environment."We are introducing Bond ETFs to offer clients a more flexible and streamlined means of accessing the fixed-income market," said Mrs Sally Peters, Public Relations Officer at Eastern River. "The new fixed-income fund will further support this initiative by offering a stable, actively managed option focused on capital preservation and consistent yield."Scheduled to launch in Q4, the fund is designed to meet growing demand for reliable income amid ongoing interest rate uncertainty. It will leverage Eastern River's proven expertise in credit research, yield targeting, and risk management.Both the Bond ETFs and the new fund will be managed within Eastern River's active oversight framework, which prioritises downside protection and disciplined portfolio construction. Clients will benefit from improved market access, enhanced liquidity, and tailored strategies to suit evolving market conditions.These initiatives reinforce Eastern River's position as a forward-thinking bond specialist, dedicated to helping investors navigate today's market with clarity and confidence.For more information on Eastern River's forthcoming Bond ETF range and fixed-income fund, visit https://easternriver.com or contact media@easternriver.com.SOURCE: Eastern River Pty Ltd Copyright 2025 ACN Newswire via SeaPRwire.com.

DCLI Drives Fleet Efficiencies with BlackBerry Radar Deployment Across 100,000 Chassis

ONTARIO, CA, May 22, 2025 - (ACN Newswire via SeaPRwire.com) - BlackBerry Limited (NYSE:BB)(TSX:BB) today announced that Direct ChassisLink, Inc. ("DCLI"), the largest provider of container chassis to the U.S. intermodal industry, will deploy BlackBerry® Radar® across 100,000 of its DCL53 domestic 53-foot chassis. The rollout is part of a major initiative DCLI is undertaking to enhance the quality, reliability, visibility and operational efficiency of its fleet, with a view to setting a new freight industry standard for data driven decision-making.The deployment represents a deepening in the companies' technological collaboration. DCLI has utilized Radar devices on a subset of its fleet for over five years and after seeing the reliability and intelligence they provide, decided to exponentially increase the number of its chassis deployed with the solution while also recognizing Radar as a top tier supplier.With the BlackBerry Radar asset monitoring solution, DCLI will gain operational visibility, enabling its customers to optimize asset utilization and deliver more streamlined operations. Thanks to the steady stream of near real-time information Radar provides, DCLI will benefit from precise asset tracking, advanced inventory insights, location-based alerts, and optimized driver and terminal efficiency. Integrated sensors will streamline billing processes and enhance fleet optimization, enabling real-time monitoring of chassis to reduce delays and improve logistics planning.The rollout of the technology also reinforces DCLI's commitment to fleet safety and reliability by improving maintenance visibility and response times. This includes preparedness for chassis requiring FMCSA inspections, optimized maintenance scheduling, and enhanced responsiveness for road service - all measures that help minimize downtime, assist with compliance, and help create a safer operating environment for all stakeholders."At a time where the freight industry continues to grapple with driver shortages, rising costs, and supply chain disruptions, the need for advanced asset visibility with enhanced fleet management solutions has never been more important," said Christopher Plaat, SVP and GM of BlackBerry Radar. "With the deployment of Radar, DCLI is taking a vital step in its digital transformation efforts. To that end, we're excited to demonstrate the countless data-driven insights that can be unlocked when you have improved visibility into the status of your chassis. We look forward to continually improving our platform based on customer use cases and feedback.""At DCLI, quality is a top priority, and this initiative reflects our dedication to delivering exceptional value to our customers," said Lee Newitt, chief executive officer at DCLI. "Equipping our entire DCL53 chassis fleet with GPS technology is a testament to our ongoing mission to lead the intermodal industry with innovative solutions and unparalleled fleet quality."BlackBerry Radar is an easy-to-install, asset monitoring solution for chassis, trailers, containers, and railcars, and provides near real-time information around location, cargo load status, motion, mileage, temperature, humidity, door open/close status, handbrake engaged status, and impact events through an intuitive dashboard. A device-agnostic platform that provides customers with a single pane of glass view for their asset management needs, with BlackBerry Radar, all data is transmitted and stored securely on a cloud platform, which maintains the privacy of user information at all times.To find out more about BlackBerry Radar, visit www.blackberry.com/radar.About BlackBerryBlackBerry (NYSE:BB)(TSX: BB) provides enterprises and governments the intelligent software and services that power the world around us. Based in Waterloo, Ontario, the company's high-performance foundational software enables major automakers and industrial giants alike to unlock transformative applications, drive new revenue streams and launch innovative business models, all without sacrificing safety, security, and reliability. With a deep heritage in Secure Communications, BlackBerry delivers operational resiliency with a comprehensive, highly secure, and extensively certified portfolio for mobile fortification, mission-critical communications, and critical events management.©2025 BlackBerry Limited. Trademarks, including but not limited to BLACKBERRY and EMBLEM Design, QNX and the QNX logo design are the trademarks or registered trademarks of BlackBerry Limited, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services.About Direct ChassisLink, Inc. ("DCLI")DCLI is the largest provider of container chassis to the U.S. intermodal industry. Since 2009, when the company pioneered the exit of ocean carriers from the chassis business, we have generated consistent growth through expansion, acquisition, and innovation. We own, lease, and manage approx. 137,000 marine chassis and 152,000 domestic chassis with over 415 locations on or near key port facilities, depots, and intermodal hubs across the country. Since our founding, we have worked with motor carriers, ocean carriers, beneficial cargo owners, and domestic shippers to transform the way that chassis work within the intermodal supply chain. With a focus on equipment quality, operational efficiency, and delivering a great driver experience, our ultimate goal is to be the industry's chassis partner of choice. To learn more about DCLI, please visit our website at www.dcli.com.Media Contacts:BlackBerry Media Relations+1 (519) 597-7273mediarelations@BlackBerry.comDCLI Media RelationsStacy KirincicAVP, Marketing+1 (773) 793-0345stacy.kirincic@dcli.comMike O'MalleySVP Government and Public Relations, Human Resources+1 (904) 314-2152mike.omalley@dcli.comSOURCE: BlackBerry Limited Copyright 2025 ACN Newswire via SeaPRwire.com.

DCLI 部署 BlackBerry Radar 技术覆盖10万个车架,提高车队运营效率

安大略省滑铁卢, 2025年5月22日 - (亚太商讯 via SeaPRwire.com) - BlackBerry Limited(纽约证券交易所代码:BB;多伦多证券交易所代码:BB)今日宣布,美国联运行业最大的集装箱底盘供应商 Direct ChassisLink, Inc.(简称 “DCLI”)将于其10万个 DCL53 型53英尺国内底盘上部署 BlackBerry® Radar®解决方案。此次部署是 DCLI 推动提升其车队质量、可靠性、可视性及运营效率的重大举措之一,旨在通过数据驱动的决策制定,为货运行业树立新标杆。此次大规模部署标志着双方技术合作的进一步深化。过去五年,DCLI 已在部分车队中使用 Radar 设备,并充分认可其在可靠性和智能性方面的表现。基于出色的使用效果,DCLI 决定大幅扩大该技术的应用范围,并将 Radar 评为顶级供应商之一。借助 BlackBerry Radar 资产监控解决方案,DCLI 将获得更强的运营可视性,帮助客户优化资产利用率,实现更加高效的运营管理。Radar 提供持续、接近实时的信息流,使 DCLI 能够实现精准的资产追踪、先进的库存洞察、基于位置的警报,以及驾驶员和货运站点效率的优化。集成传感器还将简化账单流程并提升车队优化能力,实现底盘的实时监控,从而减少延误并提升物流规划水平。该技术的推广还进一步强化了 DCLI 对车队安全与可靠性的承诺,通过提升维护可视性和响应速度,实现更高水平的管理。这包括针对需进行 FMCSA 检查的底盘的预备工作、优化的维护排程,以及道路救援响应能力的增强——所有这些举措都有助于减少停机时间,协助法规合规,并为所有利益相关方打造更安全的运营环境。“当前货运行业仍在应对司机短缺、成本上升和供应链中断等多重挑战,先进的资产可视化能力与增强的车队管理解决方案变得前所未有的重要,”BlackBerry Radar 高级副总裁兼总经理 Christopher Plaat 表示。“随着 Radar 的部署,DCLI 在其数字化转型中迈出了关键一步。我们很高兴展示在实现底盘状态可视化后所能释放出的无数数据洞察。我们也期待根据客户的使用案例与反馈,持续优化我们的平台。”DCLI 首席执行官 Lee Newitt 表示:“在 DCLI,质量始终是我们的首要任务,此次举措体现了我们致力于为客户提供卓越价值的承诺。为我们全体 DCL53 底盘配备 GPS 技术,正是我们持续引领联运行业、提供创新解决方案与卓越车队质量的最好证明。”BlackBerry Radar 是一款易于安装的资产监控解决方案,适用于铁路车辆、拖车、底盘和集装箱,能够提供接近实时的位置、货物装载状态、运动情况、行驶里程、温度、湿度、车门开关状态、手刹是否拉起以及冲击事件等信息,并通过直观的仪表盘呈现。该平台不依赖特定设备,为客户提供统一的资产管理视图,所有数据都通过安全的云平台传输和存储,始终保障用户信息的隐私。欲了解更多关于 BlackBerry Radar 的信息,请访问:www.blackberry.com/radar 。关于 BlackBerryBlackBerry(NYSE: BB;TSX: BB)为企业和政府提供支撑世界运行的智能软件与服务。总部位于加拿大安大略省滑铁卢,BlackBerry 的高性能基础软件帮助主要汽车制造商及工业巨头实现应用变革、开创新营收模式并推出创新商业模式,同时确保安全性、可靠性与稳定性不受影响。 凭借在安全通信领域的深厚积淀,BlackBerry 提供全面、高度安全并经过严格认证的产品组合,涵盖移动防护、关键任务通信及重大事件管理,以确保业务持续运行与运营韧性。商标声明:包括但不限于 BLACKBERRY 及 EMBLEM Design 及 QNX 及 QNX logo在内的商标均为 BlackBerry Limited 的商标或注册商标,BlackBerry 明确保留其专有权利。所有其他商标均为其各自所有者的财产。 BlackBerry 不对任何第三方产品或服务负责。关于 Direct ChassisLink, Inc.(“DCLI”)DCLI 是美国联运行业最大的集装箱底盘供应商。自2009年率先推动海运承运人退出底盘业务以来,公司通过不断扩张、并购与创新,持续实现稳步增长。目前,DCLI 拥有、租赁并管理约137,000个海运底盘和152,000个国内底盘,在全美关键港口设施、堆场和联运枢纽附近设有超过415个运营点。自成立以来,DCLI 一直致力于与汽车承运人、海运承运人、货主及国内托运人合作,推动底盘在联运供应链中的运作方式变革。我们专注于设备质量、运营效率以及优化驾驶员体验,最终目标是成为行业首选的底盘合作伙伴。如需了解更多信息,请访问我们的网站:www.dcli.com 。媒体联系:BlackBerry Media Relations+1 (519) 597-7273mediarelations@BlackBerry.comDCLI Media RelationsStacy KirincicAVP, Marketing+1 (773) 793-0345stacy.kirincic@dcli.comMike O'MalleySVP Government and Public Relations, Human Resources+1 (904) 314-2152mike.omalley@dcli.com来源: BlackBerry Limited Copyright 2025 亚太商讯 via SeaPRwire.com.

中信国际电讯CPC信息安全方案及SOC服务实力获市场认可

香港, 2025年5月22日 - (亚太商讯 via SeaPRwire.com) - 中信国际电讯集团有限公司(「中信国际电讯」,香港交易所股份代号:1883)全资拥有的中信国际电讯(信息技术)有限公司(「中信国际电讯CPC」) 欣然宣布接连在多个国际奖项中夺得佳绩。近日知名IT行业媒体《IT PRO》在4月进行的「IT PRO企业SOC调查[1] 」结果正式发布,中信国际电讯CPC荣幸地获选为可信赖的香港安全运作中心 (SOC) 前三甲,杰出表现备受业界及市场肯定,也充分展现其在安全运营领域的技术实力和市场领导地位。此外,连续三年参与的「2025网络安全卓越奖」中更一举勇夺三大奖项。而凭借人工智能技术打造之创新「AI渗透测试 (AI Pentest)」安全方案,项目同时获得「2025亚太史蒂夫®奖」的「数字化转型创新奖-电讯业」金奖,和再度蝉联《Computer Weekly》「2025 亚太区创新奖」。中信国际电讯CPC荣获多个国际行业殊荣,包括:- 香港安全运作中心(SOC)前三甲- 连续三年夺得「2025网络安全卓越奖」,斩获三大奖项AI安全解决方案年度SOC团队最佳托管安全服务供应商(MSSP)- 荣获「2025亚太史蒂夫®奖」的「数字化转型创新奖-电讯业」金奖- 蝉联《Computer Weekly》「2025 亚太区创新奖」中信国际电讯CPC行政总裁黄政华先生表示:「赢得多个知名机构认可并颁发的奖项,我们深感荣幸。也成为动力驱策我们要加快创新步伐,突破框限,追求更佳成绩。我们的AI-SOC安全运作中心在该市场调研中获评为香港前三强,结果不仅展示了SOC的综合实力,也是对我们深厚积累的服务经验与技术投研能力的双重肯定。过去多年团队积极革新创新,以AI赋能企业提升防御能力,确保安全运营。我们的AI创新应用不但屡获国际奖项,展现数智实力。未来,中信国际电讯CPC将继续推动以智能SOC服务为核心,加入更多AI功能及增值服务,打造更完备的数据安全底座,致力成为客户首选。」获评《IT PRO》香港SOC三强|自建三地架构,赋能出海进华企业中信国际电讯CPC凭借高质量的SOC服务能力,于《IT PRO企业SOC调查》中,获评为香港SOC服务供应商前三甲。据该调查显示,企业客户更重视SOC服务的「安全事故调查、分析、定期会诊」,而挑选SOC供应商两大准则,分别是「用户推荐及跟进事件体验」与「安全服务水平合乎预期」,而中信国际电讯CPC凭借跨地域SOC服务及全天候AI驱动的威胁防护方案脱颖而出。跨地连接、安全无忧:中信国际电讯CPC的专业优势1.跨地域自营SOC中心:拥有近20年安全服务经验,少数在中港两地提供「自建、自营、自管」跨地式双SIEM SOC服务平台的供应商,以香港、广州及上海三地SOC中心为支撑,服务全球客户,提供7x24全天候安全事件管理。2.提供一站式云网安服务:全球化网络资源布局及设有20个云服务中心,少数能提供一站式无缝「云网」安全连接的安全服务供应商。3.拥有专业技术及客服团队:少数单一安全服务供应商能提供一站式「云网安」管理服务,从网络建设、关键应用(如CRM、ERP),到不同技术厂商的设备管理,简化企业IT运维。4.AI 创新能力:通过「AI攻防」红蓝队演练,结合崭新AI智能分析实现主动防御,精准识别潜在攻击,为企业提供实时威胁应对与安全托管服务。5.跨境数据合规管理:团队了解各地安全威胁模式、风险资讯及合规要求,能为出海进华企业量身定制全方位安全防护策略。专业团队 服务在地 全天候为企业提供安全保障2025网络安全卓越奖是一项全球性的年度盛事,由业界权威资安网络社群 Cybersecurity Insiders主办,旨在表彰在信息安全领域展现优异成就、创新精神和领导风范的公司、产品和专业人士。中信国际电讯CPC非常荣幸以AI 创新能力、安全专家和信息安全管理服务在2025年网络安全卓越奖获得三大奖项-AI安全解决方案(AI Security Solutions)、年度SOC团队(SOC Team of the Year)以及最佳托管安全服务供应商(Best Managed Security Service Provider (MSSP) )。年度SOC团队的荣誉印证了中信国际电讯CPC在安全领域的领导者地位。凭借拥有7x24专业团队,持有国际认证证书如CISA、CISSP、CCIE-RS及PMP等,融合他们对服务不同地区及行业的经验,展示对各种安全领域的理解和快速回应;团队秉承「以客为本」的服务理念,为每个客户定制安全解决方案,满足其独特场景和法规要求;结合「AI攻防」的创新实践概念,通过红蓝队模拟练习,实现主动防御,识别潜在漏洞并迅速采取措施,确保组织有效地应对网络威胁。AI创新能力 打造更高效的数字化未来中信国际电讯CPC的AI Pentest凭借优质的创新应用,荣获「2025亚太史蒂夫®奖」的「数字化转型创新奖-电讯业」金奖;并蝉联《Computer Weekly》「2025 亚太区创新奖」。作为TrustCSI 3.0™ 云网神盾的核心方案,AI Pentest采用独特的AI驱动绕过技术,能自动识别WAF潜在漏洞,并通过自动化的例行任务调度,实现7x24无间断的内部网络资产评估。这款轻量级智能化解决方案如同「网络AI扫地机器人」,不仅大幅提升漏洞检测效率,更帮助企业在快速变化的数字环境中建立主动防御体系。黄政华先生续说:「我们将持续推动AI技术与网络安全的深度融合,助力客户实现安全运营的自动化与智能化,共同迈向更安全、更高效的数字化未来。中信国际电讯CPC的专业团队将充分发挥专业能力,与AI技术结合,进一步强化客户的安全防护,我们的SOC(安全运作中心)也借此迈进 AI 驱动的新时代,计划于下半年度提供第三个『自主研发』并备有AI技术的SIEM技术平台,赋能企业以更具成本效益、更高效率应对网络威胁,加速实现安全与数字化转型的双轨并进。」[1] 调查是根据IT PRO 于2025年4月向逾12,000名本地企业中至高层人员发电邮问卷进行的线上调查。原文: https://itpromag.com/2025/05/16/it-pro-soc-result中信国际电讯CPC简介中信国际电讯(信息技术)有限公司(「中信国际电讯CPC」)是中信国际电讯集团有限公司(香港交易所股份代号:1883)的全资附属公司,一直矢志透过先进技术及旗舰解决方案,包括TrueCONNECT™专用网络服务、TrustCSI™信息安全解决方案、DataHOUSE™全球统一云数据中心解决方案及SmartCLOUD™云端运算解决方案,为全球跨国企业提供综合数码解决方案,满足不同行业的ICT服务需求。凭借「创新‧不断」的服务理念,中信国际电讯CPC积极利用创新技术,提炼"技术赋能",将人工智能、扩增实境、大数据、物联网和其他尖端新兴技术,融合深度学习及智能数据分析技术,转化为"数据赋能"生成式AI+应用,重塑企业智能营运之旅。中信国际电讯CPC以「服务在地,连接全球」的优势,承诺为客户提供最优质的一站式ICT服务。全球化网络资源连接近170个服务据点、60多个SDWAN 网关;20个云服务中心、30多个数据中心及3个全天候运作的安全运作中心,服务遍布逾160个国家和地区,无缝连接亚洲、欧美、非洲、中东以及中亚等地区。透过全球化服务布局,多年不断深耕各个行业与领域经验,一系列国际认证(SD-WAN Ready、ISO 9001、14001、20000、27001 及27017),确保为企业提供国际化标准及专业在地服务能力,成为客户信赖的信息智能化服务供应商。请浏览www.citictel-cpc.com获取更多资讯。传媒查询:Catherine Yuen中信国际电讯CPC(852) 2170 7536电邮:catherine.yuen@citictel-cpc.com Copyright 2025 亚太商讯 via SeaPRwire.com.